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ABSTRACT 
Cancer is defined as the abnormal growth of genetically mutated or perturbant cells. 
Nicotine is a known cancer promoter and an apoptotic suppressor. This alkaloid acts 
on the nicotinic acetylcholine receptors which affects the ubiquitin-proteasome 
protein degradation pathway and ultimately hinders apoptosis. The endoplasmic 
reticulum (ER) is an interconnecting organelle which synthesises proteins and its 
quality control processes ensures the proper protein folding, post-translational 
modifications and conformation of secretory and trans-membrane proteins. Studies 
demonstrated that the antibiotic, Tunicamycin (Tm) and the sesquiterpene lactone, 
Thapsigargin (Tg) causes ER stress and consequently cellular arrest. Tm interferes 
with N-glycosylation of newly synthesised proteins triggering the unfolded protein 
response, while Tg inhibits intracellular Ca2+ ATPases resulting in increased cytosolic 
Ca2+. Studies showed that these compounds have potential pro-apoptotic effects. The 
combinatorial effects of nicotine, Tm and Tg may produce antagonistic or synergistic 
effects and provide a therapeutic tool against breast cancer.  
The aim of the study was to determine the apoptotic effects of nicotine, Tm, and Tg 
on  human breast carcinoma (MCF-7) at various time intervals and further to elucidate 
whether selected ratios of their combinations resulted in synergistic or antagonistic 
effects. 
 MCF-7 cells were exposed to various concentrations of nicotine (0.1 nM to 1 mM), 
Tm (0.1 nM to 1 µM), and Tg (0.1 nM to 1 µM) at 24, 48 and 72 hrs to determine cell 
viability, ATP activity, DNA proliferation and early apoptosis. The combinatorial 
concentrations of nicotine with Tm and nicotine with Tg were at selected 1:1 ratios 
for the analysis of the above mentioned parameters. Data was analysed using 
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GraphPad Prism 5 and the MedCalc, Mann-Whitney test for not-normally distributed 
unpaired samples. Statistical significances was denoted as p<0.05. 
Results in this study demonstrated that: 
(1) MCF-7 cell viability was unaffected by the selected concentrations of nicotine at 
24, 48 and 72 hrs. Results showed consistently high levels of ATP and DNA 
proliferation and nicotine did not induce early apoptosis.  
(2) Tm exposure resulted in a significant decrease (p≤0.0159) in viability. There was 
a noticeable decrease in ATP production (p≤0.005), a marked elevation 
(p≤0.0286) in DNA proliferation and also induction in early apoptosis between 
24 and 72 hrs. 
(3) Tg resulted in a noticeable decrease (p≤0.001) in viability and ATP concentrations 
(p≤0.009) between 24 and 72 hrs. There was a significant increase in DNA 
proliferation (p≤0.0286) and Tg induced early apoptosis at 24 hrs only at 0.4 µM. 
Significant apoptotic effects were observed at 48 and 72 hrs. 
(4) Combinatorial effects of nicotine and Tm (1:1 ratios) resulted in a significant 
decrease (p≤0.05) in viability between 24 and 72 hrs. The ATP levels noticeably 
decreased (p≤0.0286) while % DNA significantly increased (p≤0.0286) between 
24 and 72 hrs. The nicotine and Tm combination induced apoptosis in MCF-7 
cells. 
(5) Combinatorial effects of nicotine and Tg (1:1 ratios) resulted in the marked 
decrease (p≤0.0001) in viability and ATP concentrations (p≤0.0286) while DNA 
proliferation significantly increased (p≤0.0286) between 24 and 72 hrs. Apoptosis 
was induced only at 48 hrs. The combination Tg and nicotine could not induce 
apoptosis at 24 and 72 hrs, except at 1:1 ratio of 5 µM at 72 hrs. 
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(6) Selected concentrations of Tg in combinations with 0.105 µM Tm resulted in a 
significant decrease (p≤0.0022) in viability, ATP levels (p≤0.0286) and lowered 
DNA concentrations (p≤0.05) between 24 and 72 hrs. Increased Tg 
concentrations resulted in greater inhibition of viability. Results also showed that 
the combinations could induce apoptosis in MCF-7 cells. 
(7) Selected concentrations of Tm in combination with 0.06 µM Tg resulted in a 
marked decrease (p≤0.0022) in cell viability, ATP levels (p≤0.0286) and lowered 
DNA concentrations (p≤0.00238) between 24 and 72 hrs. Increased Tm 
concentrations resulted in a lowered inhibition of viability. Results also showed 
that the combinations could induce apoptosis after 48 hrs in MCF-7 cells. 
 
It was concluded from this study that nicotine supported MCF-7 cell growth while Tm 
and Tg displayed apoptotic effects. Nicotine suppressed the apoptotic effects of Tm 
and also reduced its cytotoxicity. Nicotine and Tg combinations only induced 
apoptosis at 48 hrs, suggesting that nicotine could suppress the apoptotic effects of Tg 
after 72 hrs. This finding implies that the apoptotic effects of Tg were reversible. This 
is the first study to report on the combinatorial effects of Tm and Tg which 
demonstrated their synergistic apoptotic effects in MCF-7 cells. 
 
Keywords: Nicotine, tunicamycin, thapsigargin, endoplasmic reticulum, apoptosis   
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CHAPTER 1 
1. Introduction 
1.1 Cancer  
Cancer is defined as the abnormal growth of mutated cells (Fig. 1). These cells may 
be altered genetically or result from a perturbation of normal cell function. Malignant 
cancer cells spread readily through the lymphatic system and have the ability to 
proliferate uncontrollably and invade other tissue sites to establish secondary tumours 
or metastasis, while benign tumours do not spread through the lymphatic system and 
remain in their site of origin (Dervan, 2001 and Löwy, 2010).  
Cancers are divided into subtypes which are dependent on either the cell type or the 
region it occurs in. The main categories of cancer include: (i) Carcinoma which is a 
cancer that begins in the skin or in tissues that line or cover internal organs, (ii) 
Sarcoma, a cancer that begins in bone, cartilage, fat, muscle, blood vessels, or other 
connective or supportive tissue, (iii) Leukemia which starts in blood-forming tissue 
such as the bone marrow and causes large numbers of abnormal blood cells to be 
produced and enter the blood, (iv) Lymphoma and myeloma, cancers which originate 
from cells of the immune system, and (v) Central nervous system cancers that begin 
in the tissues of the brain and spinal cord (Dervan, 2001 and Löwy, 2010). 
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Fig. 1. Comparison of cell proliferation in normal and cancerous cells (National 
Cancer Institute:http://www.cancer.gov/cancertopics/cancerlibrary/what-
is-cancer). 
During tumourigenesis, tumour suppressor genes (TSGs) are downregulated due to 
anomalous promoter methylation, and may be used as a marker for early diagnosis of 
numerous carcinomas.  It has been reported that protein ubiquitylation is a crucial 
aspect in a variety of biological processes as well as cell proliferation, cell cycle, 
apoptosis, signal transduction, especially in breast cancer (Xiang et al., 2012). 
Ubiquitin carboxyl-terminal esterase L1 (UCHL1), serves as a dual-regulator of the 
ubiquitin proteasome pathway, in which it controls cytosolic protein stability by 
transferring ubiquitin directly to protein substrates and releasing ubiquitin from 
repeatedly conjugated ubiquitin monomers (Xiang et al., 2012). Xiang and coworkers 
(2012) also recognized that UCHL1 displayed tumour suppressor characteristics by 
deregulating ubiquitylation of p53 while additionally stimulating p53, consequently 
preventing cell replication and bringing about apoptosis in cancerous cells. 
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Amongst the most common cancers to affect females, breast carcinoma is the leading 
cancer associated with mortality. While major advancements have been achieved in 
attempting to understand, diagnose and manage breast cancer, early detection methods 
are still severely restricted (Xiang et al., 2012) and thus still leaves clinicians with the 
challenge of effective and non-invasive therapy. 
1.2  Breast cancer 
 
Jemal and associates (2011) reported that the leading cause of cancer deaths in 
females in developing countries had shifted from cervical to breast cancer in recent 
years. Mortality associated with breast cancer accounts for 14% of all diagnosed 
cancer cases. In 2008, the World Health Organization (WHO, Globocan) reported that 
breast cancer statistics were at an 8.4% mortality rate and accounted for 11.3% of all 
cancer cases reported.  
Characteristically, there are two types of breast cancer of which ductal carcinoma is 
the most common. This type of cancer originates in the milk ducts of breast tissue. 
The other form, lobular carcinoma, may originate in the breast lobules, which 
produces the milk. Rarely does the cancer originate from other areas in the breast 
tissue. Breast cancer may be classified either as invasive or non-invasive depending 
on the nature of the tissue. Non-invasive carcinomas refer to cancerous cells which 
have not invaded surrounding healthy tissues and are referred to as “in situ”. In situ 
carcinomas, if left untreated, have the ability to progress into an invasive cancer. The 
most aggressive of the breast cancer types is lobular carcinoma in situ (LCIS), which 
is also a marker for an increased risk of malignancy. However, ductal carcinoma in 
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situ (DCIS), found in the lining of the milk ducts, only become progressive if left 
untreated (Dervan, 2001and Löwy, 2010).  
Breast cancer progression is also characterized by surface receptors exhibiting 
hormonal sensitivity, or an increase in gene expression by the cancer cells. Estrogen 
receptor-positive cancer (ER-positive cancer), are cancers with an increased 
expression of estrogen receptors on the cell surface. This results in an increased 
affinity for estrogen and thus increases the rate of progression of the cells. HER2-
positive cancer is an aggressive form of breast carcinoma due to the upregulation of 
the HER2 gene expressed in the cell. HER2 is a gene which assists in cellular 
replication and cellular repair. Women who suffer from this form of breast cancer 
have the highest incidence for recurrence of disease (Liu et al., 2012).  
Breast cancer is diagnosed in stages, each stage signifying the progression of the 
cancer and consequently affects the treatment options. Diagnoses at stages 0, I, II, or 
III, are usually prescribed with treatment to eradicate and prevent relapses. At stage 
IV, practitioners are only able to assist in prolonging and increasing the current 
quality of the patients life (Dervan, 2001 and Löwy, 2010).  
Therapy is usually dependent on the stage of invasion and may include surgery, 
lumpectomy or mastectomy, radiation and chemotherapy. Radiation and surgery are 
considered local treatments in which only a designated area is targeted. Chemotherapy 
however, is a systemic treatment option and affects the whole body (Dervan, 2001 
and Löwy, 2010). 
A hormonal therapeutic approach is employed in ER-positive cancers, in which 
Tamoxifen is the hormone used to inhibit estrogen from binding to the receptor, 
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thereby decreasing progression of the cancer. Another estrogen inhibitory drug 
prescribed for ER-positive cancer is exemestane, a class of aromatase inhibitors, 
which is prescribed for post-menopausal women (Gross et al., 2011). As for HER2 
positive cancers, trastuzumab (Herceptin®) is used in their treatment. Chan and co-
workers (2005) reported that patients who had no prior chemotherapy treatment had a 
response rate of 23-26% when treated with trastuzumab. 
1.3 Endoplasmic Reticulum 
 
The endoplasmic reticulum (ER) is a large membranous organelle that interconnects 
the plasma membrane, the cytoplasm and the nucleus (Fig. 2). The ER has multiple 
major physiological functions and is the site for the biosynthesis of proteins, sterols, 
lipids and glycoproteins (Yoshida, 2007 and Xu et al., 2005). Newly synthesised 
polypeptide chains are folded and assembled in the ER lumen with the aid of 
molecular chaperones (Wang et al., 2010). These quality control processes ensure the 
proper protein folding, post-translational modifications and conformation of secretory 
and trans-membrane proteins.  Unfolded or improperly folded proteins are restricted 
from exiting and held within the ER for proteasomal degradation via ER-associated 
protein degradation (ERAD). The ER lumen also stores intracellular Ca2+ needed for 
many cellular signalling processes (Schröder, 2007) such as signal transduction 
(Takadera et al., 2007).   
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Fig. 2. Endoplasmic reticulum activities and responses to stress 
(http://www.rikenresearch.riken.jp/eng/frontline/6085). 
 
1.3.1 
 
ER stress 
ER stress is triggered when any of the ER functions fail to ensure homeostatic 
(steady-state) levels between properly folded and misfolded proteins. Accumulation 
of inadequately folded proteins interferes with the ER folding capacity leading to 
cellular proteotoxicity. The protein folding apparatus has multiple chaperones, e.g., 
Hsp70, Hsp90 and lectin. Each chaperone works in a hierarchical manner in which, 
for example, Hsp70s are involved with completely unfolded or unstructured 
polypeptide chains, while Hsp94 and lectin are more focused on partly folded proteins 
(Schröder, 2007). Hsp70 chaperone, such as glucose-regulated protein 78/GRP78, 
immunoglobulin heavy chain binding protein/BiP (GRP78/BiP) has a higher affinity 
for unfolded polypeptides bound to ADP than those bound to ATP. Thus, ATP-ADP 
exchange is required during these mechanisms, or unfolded chains will accumulate 
and cause ER stress (Schröder, 2007). GRP78 is a protein released due to the chronic 
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stimulus of ER stress and promotes cell survival, proliferation and shelters cells from 
certain chemotherapeutic drugs (Hsu et al., 2009).  
 
As ER proteins increase during stress, GRP78 expression is also upregulated. This 
upregulation can function as an anti-apoptotic trigger of GRP78 formation, prevent 
the activation of caspase cascades and function as a protector against apoptosis (Hsu 
et al., 2009). The accumulation of perturbant ER proteins leads to stress conditions 
within the organelle and persistence of this stress may result in the ultimate suicide of 
the cells (Nakayama et al., 2009). Unfolded proteins may also accumulate when 
disruptions to the Ca2+ gradient occurs. ER stress, in turn, activates the unfolded 
protein response (UPR) (Schröder, 2007), which attempts to alleviate ER stress (He et 
al., 2009). Eukaryotic cells, in particular mammalian cells, have receptors that 
monitor ER stress and protein accumulation. These receptors are PRK-like ER 
resistant kinase (PERK), activating transcription factor 6 (ATF6) and inositol 
requiring enzyme 1 (IRE1) (Wang et al., 2010). The ER stress triggers a homeostatic 
mechanism to relieve the stress caused by the accumulation of misfolded proteins, by 
facilitating the removal of perturbant proteins from the ER via the UPR (He et al., 
2009).   
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 1.4 Nicotine 
 
 
Fig. 3. Molecular structure of (-).(S)-nicotine (Clayton et al., 2010) 
 
Nicotine is the principal toxic alkaloid in tobacco and cigarette smoke. This alkaloid 
(C10H14 N2) has a molecular weight of 162.23 g/mol and functions as a tumour 
promoter by disturbing cellular progression though the cell cycle (Zeidler et al., 
2007). This compound is extracted from the tobacco plant which is part of the 
Solanoceous plant family, also included in this family are the potato, green pepper 
and tomato plants (Yildiz, 2004).  Nicotine is known for stimulating transcription 
factors, such as c-fos and c-Jun, suppressing apoptosis, promoting cell proliferation 
and expressing heat shock proteins (Hsp60, Hsp70 and Hsp90) (Klein et al., 2001, 
Dasgupta et al., 2009). It has also been reported to exert multiple effects on normal 
and tumour tissues, including lipid peroxidation, depletion of antioxidant status via 
reactive oxygen and nitrogen species and upregulation of matrix metalloproteinases 
(Balakrishnan and Menon, 2007).   
 
This addictive and well documented notorious component of cigarettes is considered 
to be a ‘tumour enhancer’. It down-regulates important biological functions such as 
angiogenesis, and cell-mediated immunity, it also displays ‘protective’ characteristics 
such as anti-apoptosis. Nicotine binds to the nicotinic acetylcholine receptor (nAChR) 
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on neural and non-neuronal tissues. nAChRs are ligand-gated ion channels abundantly 
found within the brain (Zeidler et al., 2007). Nicotine has the ability to cross the 
blood-brain barrier (Yildiz, 2004) and, therefore, is regularly associated with studies 
regarding neural diseases such as Alzheimer’s and Parkinson’s. 
 
Stereoisomeric forms of nicotine are important for the effectiveness and potency of 
the drug in biological systems. Nicotine has two subtypes, (2)-(S)-nicotine (Fig. 3), 
and (1)-(R)-nicotine, of which the former is the prevalent and potent alkaloid in 
tobacco (Clayton et al., 2010).  
1.4.1 Metabolism of Nicotine 
Nicotine is absorbed into the bloodstream in the pharmacologically active (S)-nicotine 
form. In the liver, it is converted to its major metabolites, namely; cotinine, nicotine 
N'–oxide (NNO), nicotine glucuronidate, (S)-nicotine-N-glucuronide (nicotine-Gluc) 
and nornicotine. This compound is converted by P450 cytochrome (CYP) enzymes to 
iminium ion, which is subsequently transformed to cotinine by means of the enzyme 
aldehyde oxidase (AOX). It can further be altered into NNO via flavin containing 
monooxygenase 3 (FMO 3), which can be converted back to nicotine and reused by 
the body (Benowitz et al., 2009). Nicotine is also converted to Nicotine-Glu from N-
quaternary glucuronide, via the enzymatic reaction between nicotine glucuronidation 
and uridine diphosphate-glucuronosyltransferase (UGT) (Benowitz et al., 2009). 
Cotinic metabolites are readily excreted in the urine (Klein et al., 2001). The primary 
and secondary identified metabolites excreted by smokers are 3'-hydroxycotinine 
(3HC), and glucuronide conjugate (3HC-Gluc), respectively (Klein et al., 2001). 
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Between 40 and 60% of the nicotine intake is detected as 3HC and 3HC-Gluc in the 
urine and only 1% from norcotinine (Klein et al., 2001).  
1.4.2 Nicotine and cancer 
 
Nicotine oxidation is primarily catalysed by CYP P450 enzymes (Fig. 4) via 
5'hydroxylation to yield an unstable intermediate metabolite 5′-hydroxynicotine that 
exists in equilibrium with nicotine-1′(5′)-iminium ion (Benowitz and Jacobs III, 
1994). However, Hecht and co-workers (2000), demonstrated that CYP2A6 catalyses 
2′-hydroxylation of nicotine to yield a significant amount of a lung cancer-precursor, 
aminoketone. Amino-ketone is the direct precursor to the tobacco-specific lung 
carcinogen 4-(methylnitros-amino)-1-(3-pyridyl)-1-butanone (NNK) (Caldwell et al., 
1993). These findings provided the potential relationship between nicotine 
metabolism and cancer in mammals.  
 
Fig. 4. Schematic representation of nicotine metabolism within the liver 
(http://www.pharmgkb.org/pathway/PA2011) 
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1.4.3    Basic mechanism of action 
 
As mentioned previously, this compound binds to the nAChRs on neuronal and non-
neuronal cells (Zeidler et al., 2007). It also (as part of its mechanism of action) affects 
the ubiquitin-proteasome protein degradation pathway components such as ubiquitin-
conjugating enzymes, 20S and 19S proteasomal subunits, and chaperonin-containing 
TCP-1 protein (CCT) complexes (Kane et al., 2004) involved in reduction of the 
cytotoxic effects of DNA-damaging agents, such as cisplatin, UV and gamma 
radiation. It decreases the c-Jun N-terminal kinase (JNK) and GADD153/CHOP 
(growth arrest and DNA damage-inducible protein, also called CHOP) cell death 
signalling pathways (Onoda,et al., 2001), activates NF-κB and GRP78/BiP, and 
induces apoptosis via Hsp90 (Paleari et al., 2009 and Crowley-Weber et al., 2003). 
1.4.4 Synergistic and antagonistic effects of nicotine 
 
Recent studies reported that nicotine, when combined with various chemotherapeutic 
drugs, inhibited the toxicity of the drugs it was combined with (Zhou et al., 2007).  
Chronic exposure to nicotine inhibits arachidonic acid-, glutamate-, and b-amyloid- 
and tunicamycin (Tm)-stimulated neurotoxicity (Zeidler et al., 2007). Multiple 
nAChRs subtypes, such as, a4b2 and a7, have been proposed to be involved in these 
protective characteristics of nicotine (Zeidler et al., 2007). Due to the anti apoptotic 
properties of nicotine, diseases such as Alzheimer’s and Parkinson’s that are 
dependent on unfolded protein accumulation and ER stress, benefit from nicotine as 
an adjunct treatment (Sasaya et al., 2008). 
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1.5 Tunicamycin 
Tunicamycin (Tm) is a prototypic antibiotic (Fig. 5) which inhibits biosynthesis of N-
linked oligosaccharides (Zhang et al., 2009) by the inhibition of UDP-N-
acetylglucosamine: dolichol/polyprenol phosphate GlcNAc-1-P transferase (GPT) 
which inhibits the primary step of protein N-glycosylation (Price and Tsvetanova, 
2007).  It has a molecular weight of 718.9 g and a molecular formula: C30H46N4O16. 
 
Fig. 5. Structure of Tm numbering system (Price and Tsvetanova, 2007) 
Tm is composed of a four ring system (A, B, C, and D), with ring D containing uracil 
and ring C N-glycosidically linked to a D-pseudoribose. Ring C is linked to D-N-acyl-
pseudogalactosamine (Ring B) by C-5–C-6. Ring B is attached by an O-glycosidic 
bond to D-Nacetylglucosamine (Ring A) (Price and Tsvetanova, 2007).  
1.5.1 Metabolism of Tunicamycin 
 
The biosynthesis of Tm lies at tunicamine, the 11 carbon dialdose sugar (link BC) and 
the αβ1- 11′′-glycosidic bound GlcNac (link B and A) (Tsvetanova et al., 2002). The 
bound GlcNAc resembles the GPT, since Tm is a transition state analog of GPT 
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(Price and Tsvetanova, 2007). Rings BCD (N-acetyl-tunicamine-uracil) is 
prospectively produced by the ligation (incorporation) of uridine-5-aldehyde (I) with 
an unsaturated 5,6-ene sugar nucleotide, UDP-4-keto-Glc(Gal)NAc-5,6-ene (II). 
However, uridine-5-aldehyde (I) is not synthesized during primary metabolism of Tm, 
which presumably occurs either as an intermediate during the biosynthesis of 
Streptomyces sp. antibiotics or from oxidation of uridine via 5-dehydrogenase or 
oxidase activity (Price and Tsvetanova, 2007). 
 
1.5.2 Tunicamycin and ER stress 
 
Hasegawa et al. (2008) and Jung et al. (2012) reported that Tm induced apoptosis via 
tumour necrosis factor-related apoptosis-inducing ligand (TRAIL). Delom et al. 
(2007) further substantiated these findings by reporting that MCF-7 cells were 
resistant to Tm-induced apoptosis due to the lack of caspase-3 expression. However, 
they all reported that apoptosis induced by Tm was enhanced with the addition of 
TRAIL and caspase-3. Apoptosis in Tm-induced cells were as a result of the 
inhibition of glycosylation and accumulation of unfolded and misfolded proteins 
causing the cell to undergo ER stress (Sasaya et al., 2008). It is this inhibition of 
newly synthesised proteins that may lead to aberrant post translational modifications 
of important proteins, and ultimately creating ER stress (Yaun et al., 2007). The ER 
stress triggers a homeostatic mechanism by facilitating the removal of those 
perturbant proteins. This mechanism is known as the unfolded protein response (UPR) 
(He et al., 2009).  Inadequate UPR may lead to increased cytosolic proteins and cause 
apoptosis in various cell types (Nakayama et al., 2009) (Fig. 6). 
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Fig. 6. The effect of tunicamycin in the ER 
(http://www.nature.com/nrc/journal/v4/n12/fig_tab/nrc1505_F1.html) 
 
1.6 Thapsigargin 
 
Fig. 7. Chemical structure of Thapsigargin (Ball et al., 2007) 
Thapsigargin (Tg) has a molecular weight of 650.75 g and the molecular formula, C34 
H50 O12 (http://pubchem.ncbi.nlm.nih.gov). Important cellular functions such as signal 
transduction rely on regulation of calcium ions by the ER. Tg inhibits the Ca2+ATPase 
and causes an increase in cytosolic Ca2+ (Takadera et al., 2007, Thastrup et al., 1990). 
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Thus, this Ca2+ flux perturbant may be used to induce ER stress (Zhang et al., 2009, 
Shu et al., 2008 and Sasaya et al., 2008). Tg does not only act on the ER and 
intracellular Ca2+ signalling pathways (Ball et al., 2007), but has the ability to diffuse 
across cell membranes and inhibit the sarcoplasmic endoplasmic reticulum calcium 
ATPase (SERCA) (Shimoke et al., 2005). Intracellularly, Tg rapidly increases 
cytosolic sequestered Ca2+ by overstimulation of the ER, Ca2+ permeates through Ca2+ 
pores and with it releasing, inositol 1,4,5 trisphosphate and guanosine-5'-triphosphate 
(GTP) (Thastrup et al., 1990). Due to Tg’s lipophilic nature, it converts into a 
structure with poor affinity for Ca2+ and ATP. The weakened affinity for Ca2+ inhibits 
the sequestering of intracellular Ca2+ and consequently, a secondary accumulation of 
extracellular Ca2+ would occur, thus causing ER stress and leading to apoptosis (Ball 
et al., 2007). Some neurological diseases may be linked to uncontrolled Ca2+ secretion 
such as stroke and Alzheimer’s disease (Takadera et al., 2007). 
1.6.1  Metabolism of Thapsigargin 
Thapsigargin is a sesquiterpene lactone isolated from the umbelliferous plant Thapsia 
garganica L. (Apiaceae), which is largely distributed in the Mediterranean, on the 
Spanish peninsula, and in North Africa. Tg was identified as its principle skin-
irritating compound. Interestingly, Tg is reported to have been used in Arabian folk 
medicine as a counter-irritant (Christensen and Norup, 1985). Sesquiterpene lactones 
belong t a class of chemical compounds which contain a lactone ring, found in many 
plants, known to cause allergic reactions and toxicity at high doses, particularly in 
grazing livestock  
(http://www.ansci.cornell.edu/plants/toxicagents/sesqlactone/sesqlactone.html).  
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The complete biosynthesis of thapsigargin has not as yet been elucidated. However, 
there is a proposed biosynthetic pathway (Drew et al., 2009). Biosynthesis is initiated 
with common terpene farnesyl pyrophosphate controlled by the enzyme, germacrene 
B synthase.  Subsequently, the C(8) position is activated for an allylic oxidation due 
to the position of the double bond. This is followed by the addition of the acyloxy 
moiety by a CYP450 acetyltransferase. The lactone ring is then formed by a 
cytochrome P450 enzyme using NADP+. However, because of the butyloxy group on 
the C(8), the formation will only generate the 6,12-lactone ring. An epoxidation step 
that initiates the last step of the base guaianolide formation uses a CYP450 enzyme 
that closes the 5 + 7 guaianolide structure. The ring closing is critical, in order to 
retain the 4,5 - double bond needed in thapsigargin. It has been reported that several 
of these enzymes are CYP450's and therefore oxygen and NADPH are likely to be 
crucial for its biosynthesis as well as other cofactors such as Mg2+ and Mn2+(Drew et 
al., 2009). 
1.6.2 Thapsigargin and ER stress 
 
Tg inhibits SERCA, and blocks the release of Ca2+ from the ER lumen and decreases 
the affinity of GRP78/BiP for Ca2+ and its ER chaperone anti-apoptotic effects (Shu et 
al., 2008, Zhang et al., 2009 and Sasaya et al., 2008). Increases in intracellular Ca2+ 
concentration lead to the accumulation of incompetent proteins and activation of 
caspase-3-mediated apoptosis (Takadera et al., 2006) by means of the ubiquitin 
proteasome system (UPS). Tg has the ability not to activate protein kinase C or inhibit 
protein phosphatase, yet it is a naturally occurring sesquiterpene. Thastrup and co-
workers (1990) reported that Tg acts by directly inhibiting ER Ca2+-ATPase resulting 
in the release of all sequestered Ca2+ as well as, Ca2+ (ATP-dependent) from 
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microsomal membrane vesicles (Thastrup et al., 1990). Tg could, therefore, provide a 
valuable tool against breast cancer by altering the cell’s Ca2+ levels and inducing 
cellular arrest. 
 
The aim of this study was to investigate the effects of tunicamycin (Tm), thapsigargin 
(Tg) and nicotine (Nic) on growth and apoptosis of human breast carcinoma (MCF-7) 
cells. The objectives included (i) determining the effects of the compounds at selected 
concentrations on cell viability, ATP concentration, DNA proliferation and early 
apoptosis at 24, 48 and 72 hrs, (ii) to analyse the combinatorial effects of Nic, Tm and 
Tg on the above parameters in order to counter the pro-apoptotic properties of 
nicotine and simultaneously support apoptosis in MCF-7 cells. 
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CHAPTER 2 
2. MATERIALS AND METHODS 
2.1 Materials 
 
Human breast cancer (MCF-7) cells were donated from the Human Biology 
Department at The University of Cape Town and placed in cell culture which were 
maintained in Dulbecco’s modified Eagle medium (DMEM)/Nut medium (Mix F–12 
with glutamax) (Invitrogen, Germany), supplemented with 10% Foetal bovine serum 
(FBS) (Invitrogen, Germany) and 1% penicillin, streptomycin (pen-strep) (Sigma- 
Aldrich, SA), at 37°C, 5% CO2 in a humidified atmosphere. Before conducting 
experiments, cells were washed in 1X phosphate buffered saline (PBS) (Invitrogen, 
Germany). Adherent cells were brought into suspension by trypsinating with 0.25% 
trypsin/EDTA (Invitrogen, Germany).  
Suspended cells were used to conduct the following experimental procedures: Cell 
viability was determined by means of 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) (CAS: 298-93-1; Sigma, SA). ATP production 
was determined using Promega CellTiter Glo® Luminescent Cell viability assay 
(Cat# G7571) (Promega, SA). DNA proliferation was assessed by means of BrdU 
Cell proliferation ELISA Chemiluminescence assays (Cat# 11669915001) (Roche, 
Germany). Early apoptosis was investigated using, Annexin V:FITC (cat# 
AN300FITC) (AbDserotec; Europe). MCF–7 cells were exposed to various 
concentrations of tunicamycin (CAS: 11089-65-9) (Sigma, SA), thapsigargin (CAS: 
67526-95-8) (Sigma, SA) and nicotine (CAS: 54-11-5) (Merck SA).  
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All assays, except early apoptotic detection were conducted in flat-bottomed 96-well 
microtiter plates (LASEC and Biosmart, SA) and absorbance and luminescence were 
read using the Glomax multidetection system. (Serial No: 51187002). Early apoptosis 
was analysed by means of flow cytometry using the Becton Dickinson FACSCalibur 
(serial no: E2023) flow-cytometer with a 488 nm Coherent laser. The software used 
for the acquisitioning of the data, was Cellquest Pro version 5.2.1. 
2.2 Methods 
2.2.1 Cell Viability Assay using 3-(4,5-Dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium bromide (MTT) 
  
MTT is a colourimetric assay used to detect cell viability. It uses a tetrazolium salt, 3-
[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide, which is reduced to 
purple formazan crystals (1-[4,5-Dimethylthiazol-2-yl]- 3,5-diphenylformazan) in 
living cells. The tetrazolium salt is cleaved in the mitochondria of living/viable cells 
where the redox reaction transforms the salts into formazan via the ‘succinate-
tetrazolium reductase’ system. The formazan crystals produced by the cells are a 
direct indication of the quantity of metabolically active and viable cells (Mosmann, 
1983). The formazan product was solubilised in 99% isopropanol and measured 
spectrophotometrically at a wavelength of 560 nm. 
MCF-7 cell suspension of 5000 cells in 100 µl, was added to each of the experimental 
wells of a clear 96-well microtiter plate. Cells were allowed to attach by incubating 
for 24 hours at 37°C in a 5% CO2 humidified atmosphere. After 24 hours, various 
concentrations of drugs were prepared on the day in pre-warmed supplemented media. 
Supernatant from experimental wells were aspirated and cells were treated with 100 
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µl of the compound dilutions. Controls, ran in parallel to the experimental wells, and 
contained only media (blanks). The concentrations of the pure compounds (Table 1) 
and the combinations of these compounds are presented in Tables 2 and 3.   
Table 1:  Pure compound concentrations (µM) used for cell viability 
determination (n≥6) 
Pure Compounds 
Tunicamycin Thapsigargin Nicotine 
0.0001 0.0001 0.0001 
0.001 0.001 0.001 
0.0039 0.01 0.01 
0.0078 0.0125 0.1 
0.01 0.025 1 
0.0156 0.05 10 
0.03125 0.1 100 
0.0625 0.2 1000 
0.1 0.3  
0.125 0.4  
0.25 0.8  
0.5 1  
1   
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Table 2:  Selected concentrations (µM) of nicotine in combination with 
tunicamycin and thapsigargin (1:1) ratio used for cell viability 
determination (n≥6) 
Nicotine Combinations 
Tm : Nic Tg : Nic 
0.0001 0.0001 
0.001 0.001 
0.01 0.01 
0.1 0.1 
1 1 
10 5 
100 50 
200  
300  
400  
500  
1000  
Tm = Tunicamycin, Tg = Thapsigargin, and Nic = Nicotine 
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Table 3:  Selected combinatorial concentrations of tunicamycin and 
thapsigargin (µM), using concentrations below IC50 for cell 
viability determination (n≥6) 
Tm : Tg combination 
0.105 Tm : 0.03 Tg 0.06 Tg : 0.0525 Tm 
0.105 Tm : 0.06 Tg 0.06 Tg : 0.105 Tm 
0.105 Tm : 0.12 Tg 0.06 Tg : 0.21  Tm 
Fixed concentration of 0.105 µM Tm was combined with 
various Tg concentrations. Fixed concentration of 0.06 µM Tg 
was combined with the various Tm concentrations. 
Cells were treated (with the various compounds mentioned in Tables 1, 2 and 3) and 
incubated for 24, 48 and 72 hours. Subsequently, 10 µl of MTT (5 mg/ml) was added 
to each well, including controls and media-only wells (blanks) in minimal amount of 
light, and incubated at 37°C, in 5% CO2 for 2 hours. After the 2 hr incubation, 
supernatants were removed and 200 µl of 99 % isopropanol added to each well to 
dissolve the formazan crystals. The microtiter plate was placed on an orbital shaker 
with a microtiter plate adaptor for 25 min. Absorbance was read at 560 nm using the 
Glomax multidetection system.   
%	ܸܾ݈݅ܽ݅݅ݐݕ ൌ 	ܧݔ݌݁ݎ݅݉݁݊ݐ	 െ 	ܤ݈ܽ݊݇ܥ݋݊ݐݎ݋݈	 െ 	ܤ݈ܽ݊݇ 	ൈ 	100 
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2.2.2 Cell Titer Glo® Luminescent Cell Viability Assay 
 
This assay is used for high throughput screening, proliferation and cytotoxicity 
determinations. It is accurate and robust, in which the phenol red containing medium 
does not interfere with luminescent output. Temperature, however, greatly influences 
the rate of enzymatic reaction and, in turn, affects light intensity output. The assay 
determines cell viability via the detection of ATP activity and relies on the 
thermostable luciferase reaction. This single step assay involves adding a single 
reagent, causing cell lysis and generation of the luminescent signal, in the presence of 
ATP, Mg 2+, and molecular oxygen (Fig. 8). 
 
          Ultra Glo® Recombinant Luciferase 
 
Mg2+ 
Beetle Luciferin                                  oxyluciferin 
Fig. 8. The enzymatic reaction of luciferin in the presence of Mg2+. 
 
The selected drug concentrations used for the ATP assay were based on the IC50 
concentrations calculated from the viability assay results. Concentrations selected for 
the pure compounds and the combinations of these compounds were as follows:  
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Table 4:  Pure compound concentrations (µM) used for the determination 
of ATP and DNA proliferation (n≥6) 
Pure Compounds 
Tunicamycin Thapsigargin Nicotine 
0.25 0.05 0.0001 
0.5 0.1 0.001 
1 0.2 0.01 
1.5 0.3 0.1 
2 0.4 1 
 
 
Table 5:  Nicotine in combination with tunicamycin and thapsigargin (1:1 
ratio) concentrations (µM) used for the determination of cellular 
ATP and DNA proliferation (n≥6) 
Nicotine Combinations 
Nic : Tm   Nic : Tg 
0.01 0.01 
0.1 1 
1 5 
Tm = Tunicamycin, Tg = Thapsigargin, and Nic = Nicotine 
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Table 6:  Selected combinatorial concentrations of tunicamycin and 
thapsigargin (µM), using concentrations below IC50 for the 
determination of cellular ATP and DNA proliferation (n≥6) 
Tm : Tg combination 
0.105 Tm : 0.03 Tg 0.06 Tg : 0.0525 Tm 
0.105 Tm : 0.06 Tg 0.06 Tg : 0.105 Tm 
0.105 Tm : 0.12 Tg 0.06 Tg : 0.21  Tm 
Fixed concentration of 0.105 µM Tm was combined with 
various Tg concentrations. Fixed concentration of 0.06 µM Tg 
was combined with the various Tm concentrations. 
The experiment was conducted by seeding 5000 cells in 100 µl, into each well of  
white, flat-bottom 96-well microtiter plates. Following the addition of the selected 
drug concentrations, the cells were incubated at 37°C, in 5% CO2 for 24, 48 and 72h. 
The thawed Cell Titer Glo® buffer was transferred into the amber substrate bottle in 
order to reconstitute the lyophilized enzymes to obtain a homogenous solution as per 
the instructions of manufacturer. Prior to the addition of the reconstituted substrate, it 
was allowed to equilibrate to room temperature (RT) (±22°C). 
The microtiter plate containing the compound-exposed cells was allowed to 
equilibrate for 30 min at RT, non-sterile in minimal light exposure. 100 µl of 
reconstituted substrate was added to each of the wells, including the controls and the 
blanks. The microtiter plate was incubated for a further 2 min at RT with minimal 
light exposure before placing it on an orbital shaker for an additional 3 min. 
Luminescence was detected using the Glomax multidetection system.  
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2.2.3 DNA Proliferation Detection using 5-bromo-2`-deoxyuridine (BrdU) 
Chemiluminescent Assay 
 
DNA replication is a pivotal part of cellular survival. It identifies the proliferation 
activity of the compound induced cell. Screening for DNA production over time in the 
presence of cytotoxic or genotoxic compounds, would not only signify proliferation 
rates, but also allow for the examination of DNA synthesis and regulation. [3H]-
thymidine conventionally binds to DNA of proliferative cells. In this assay, the 
nonradioactive analogue 5-bromo-2'-deoxyuridine (BrdU) is used for the purpose of 
detecting DNA proliferation. This assay integrates the pyrimidine analogue, BrdU, 
rather than thymidine into the DNA of cells within the S phase of the cell cycle. The 
BrdU isotope is detected using ELISA techniques. 
MCF-7 cells were cultured into sterile flat bottom, black 96-well microtiter plates 
with a cell density of 5000 cells per well and incubated for 24, 48 and 72 hours at 
37°C, 5% CO2. After which, compound concentrations and combinations (as 
described in Tables 4, 5 and 6) were freshly prepared and 100 µl added to their 
designated wells, while control cells only received supplemented media. Reagents 
were reconstituted as instructed by the manufacturer. 
Preparation of Working Solutions (as per manufacturer’s instructions) 
BrdU labelling solution BrdU labelling reagent was diluted 1:100 with 
sterile culture medium (final concentration: 100 
µM BrdU). (For each well, 10% labelling 
solution was added to existing well content).  
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Anti-BrdU-POD stock solution Anti-BrdU-POD was dissolved in 1.1 ml of 
double distilled water. 
Anti-BrdU-POD working solution Anti-BrdU-POD stock solution was diluted 
1:100 with antibody dilution solution. (100 µl of 
anti-BrdU-POD working solution was added to 
each well). 
Washing solution washing buffer concentrate (10X PBS) was 
diluted 1:10 with double distilled water. (Each 
well was washed thrice with 200 µl of washing 
solution). 
Substrate solution Tetramethylbenzidine (TMB) was reconstituted 
at a ratio of 1:100. The mixture was allowed to 
equilibrate at RT for at least 15 min before 
adding 100 µl of the substrate to each well. 
After the required incubation period, 10% labelling solution was added to all wells 
including controls and blanks (media-only wells). The microtiter plate was incubated 
for 2 hrs at 37°C, 5% CO2. After 2 hrs, the media containing labelling solution was 
aspirated and 100 µl of Fix Denat was added and incubated for a further 30 min at 
RT. Subsequently the Fix Denat was aspirated and anti-BrdU-POD added, the 
microtiter plate was incubated for an additional 90 min at RT. After the incubation 
period, the anti BrdU-POD was aspirated and cells were washed thrice with 200 µl of 
washing buffer per well. Concluding the assay, a 100 µl of reconstituted substrate was 
added to each well and the microtiter plate was placed on an orbital shaker for 
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approximately 3 min, after which luminescence was detected using the Glomax 
multidetection system.  
%	ܦܰܣ	݌ݎ݋݈݂݅݁ݎܽݐ݅݋݊	 ൌ 	ܧݔ݌݁ݎ݅݉݁݊ݐ	 െ 	ܤ݈ܽ݊݇	ܥ݋݊ݐݎ݋݈	 െ 	ܤ݈ܽ݊݇	 	ൈ 	100 
2.2.4 Detection of Early Apoptosis using Flow Cytometry and Annexin 
V:FITC  
 
Annexin V:FITC (fluorescein isothiocyanate) is a fluorescent quantitative method of 
detecting apoptotic cells in a population. Annexin V is an anticoagulant protein which 
binds to negatively charged phospholipids. During early apoptosis, phospholipids are 
disrupted exposing phosphatidylserine (PS) extracellularly. The FITC conjugated to 
the annexin binds to and labels the extracellularly exposed PS. Propidium iodide (PI) 
included in the kit, binds to cellular DNA of necrotic cells. Combining these stains, 
allows for the detection of percentage of live (negative) cells, cells undergoing early 
apoptosis, cells deadas a result of apoptosis as well as dead cells (PI positive) of one 
cell population (Sigma-Aldrich). 
Cells 3x105, were seeded in 25 cm2 tissue culture treated flasks and allowed to attach 
for 24 hrs. Subsequently, the supernatant was aspirated and cells were treated with 
compound concentrations (single and combination) as described in the previous 
section (Tables 4, 5 and 6). After incubation of 24, 48 and 72 hrs, the supernatants 
were aspirated and transferred to labelled centrifuge tubes while attached cells were 
trypsinated. Once cells had detached, the trypsinated cell suspension was also added 
to the labelled centrifuge tube. The tubes were centrifuged at 2500 rpm for 2 min in 
order to pellet cells. Subsequently, the supernatant was aspirated and cells were 
resuspended in 0.5 ml binding buffer (100 mM HEPES/ NaOH, pH7.5 containing 1.4 
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M NaCl and 25 mM CaCl2), and centrifuged at 2500 rpm for an additional 2 min. 
Cells were then resuspended in 195 µl of binding buffer and 5 µl of Annexin V (50 
µg/ml), and allowed to incubate for 10 min at RT. 
After the 10 min incubation period, the cells were centrifuged at 2500 rpm for 2 min 
at RT and the supernatant aspirated. The cells were then resuspended in 190 µl of 
binding buffer and 10 µl of PI (100 µg/ml) and placed on ice with minimal light 
exposure. The samples were analysed with the Becton Dickinson FACSCalibur (serial 
no: E2023) flow-cytometer with a 488 nm Coherent laser. The Cellquest Pro version 
5.2.1 software was used for the acquisitioning of the data. The negative control 
contained unstained cells. The positive control contained 1 µM staurosporine, which 
when incubated for 3 hours, induced apoptosis, and the sample was prepared to 
contain only the Annexin V stain. Other controls included PI only stained cells, in 
which the Annexin V was omitted from the sample preparation.    
2.3 Statistical Analysis 
 
Results were analysed using GraphPad Prism 5 and MedCalc 12.2.1.0. The Mann-
Whitney test was used for non-normally distributions of unpaired samples and p<0.05 
denoted a significant event compared to controls.  
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CHAPTER 3 
 
3. RESULTS 
3.1 Effect of Nicotine on MCF-7 cells 
3.1.1 Effect on cell viability 
Table 7: The effect of selected nicotine concentrations on MCF-7 cell viability 
(Mean ± SEM) 
Concentration 
(µM) 24 Hours 48 Hours 72 Hours 
0.0001 90.261 ± 3.492 93.367 ± 4.203 114.952 ±  3.062 
0.001 89.169 ± 0.361 96.935 ± 8.357 117.902 ± 3.263 
0.01 73.459 ± 17.520 98.119 ± 2.975 111.397 ± 4.275 
0.1 77.193 ± 0.528 75.480 ± 9.365 93.440 ± 2.326 
1 114.305 ± 3.812 73.264 ± 4.701 105.418 ± 3.115 
10 101.359 ± 3.254 95.320 ± 3.706 93.904 ± 4.283 
100 98.890 ± 9.301 89.138 ± 2.941 102.528 ± 1.849 
1000 95.005 ± 4.482 115.257 ± 5.926 120.859 ± 3.200 
 
Table 7 displays the arithmetic mean and standard error of mean, of the % viability of 
cells treated with nicotine for 24, 48 and 72 hrs. MCF-7 cell viability remained above 
73% for all time intervals tested. Comparison between individual time intervals showed 
that significant differences were only observed at 0.1 nM between 48 and 72 hrs 
(p=0.0105), and 24 and 72 hrs (p=0.0105). At 1 mM concentration of nicotine, a marked 
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difference was also observed between 24 and 48 hrs (p=0.0163) and 24 and 72 hrs 
(p=0.0039).  
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Fig. 9. Effects of various nicotine concentrations on MCF-7 cell viability. 
 
Fig. 9 illustrates the effects of Nicotine on MCF-7 cells between 24, 48 and 72 hr 
incubation periods. Nicotine did not inhibit cell viability at all time intervals across all 
concentrations treated, except at 0.1 nM between 24 and 72 hrs (p=0.0105), and 48 and 
72 hrs (p=0.0105), and at 1 mM between 24 and 48 hrs (p=0.0163) and between 24 and 
72 hrs (p=0.0039).  
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3.1.2 Effect on ATP production  
Table 8: The effect of selected nicotine concentrations on ATP production in 
MCF-7 cells (Mean ± SEM) 
Concentration 
(µM) 24 Hours 48 Hours 72 Hours 
0.0001 104.173 ± 1.627 107.884 ± 1.486 113.827 ± 2.542 
0.001 105.093 ± 2.261 121.261 ± 0.744 116.158 ± 1.492 
0.01 98.707 ± 2.838 117.916 ± 1.001 120.544 ± 1.760 
0.1 105.865 ± 1.968 115.039 ± 1.314 118.939 ± 1.378 
1 106.197 ± 1.576 113.216 ± 1.012 117.108 ± 0.722 
 
Table 8 shows the effects of Nicotine on the ATP levels of MCF-7 cells. No 
difference was, observed between 0.1 nM and 1 µM at 24 hrs, 48 and 72 hr 
exposure. There was, however, a significant increase in ATP production 
between 24 and 72 hrs at all concentrations of Nicotine (p≤0.0143). 
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Fig. 10. The effects of selected nicotine concentrations on ATP production. 
 
Though a significant increase in ATP production was noted between 0.1 nM and 1 nM 
(p=0.0079) at 48 hrs, ATP levels were similar and displayed similar trends at 24, 48, and 
72 hrs at all other concentrations. % ATP production at 24 hrs was, however, markedly 
lower than those observed at 72 hrs. 
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3.1.3  Effect on DNA proliferation  
Table 9: The effect of selected nicotine concentrations on DNA proliferation in 
MCF-7 cells (Mean ± SEM) 
Concentration 
(µM) 
24 Hours 48 Hours 72 Hours 
0.0001 129.174 ± 7.276 113.552 ± 8.242 105.934 ± 26.652 
0.001 169.801 ± 1.586 126.747 ± 6.511 143.693 ± 15.249 
0.01 172.140 ± 3.026 143.712 ± 2.490 160.523 ± 13.366 
0.1 159.631 ± 4.187 138.565 ± 6.145 162.259 ± 20.163 
1 149.370 ± 1.819 129.408 ± 2.060 155.907 ± 15.587 
 
Table 9 displays DNA proliferation by MCF-7 cells when exposed to various 
concentrations of Nicotine. A significant increase was only observed between 
0.1 nM and 1 µM at 24 hrs (p<0.029). No differences were observed when 
comparing 24 and 48 hrs, 48 and 72 hrs and 24 and 72 hrs for all concentrations 
analysed. 
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Fig. 11. The effect of selected concentrations of nicotine on DNA proliferation 
in MCF-7 cells at 24, 48 and 72 hrs. 
 
Fig. 11 shows the effects of Nicotine on DNA proliferation in MCF-7 breast cancer cells. 
As the concentration increased, proliferation increased, however, proliferation reached a 
plateau at 0.01 µM at all time periods. Overall, the same trend was observed at 24, 48 and 
72 hrs between 0.1 µM and 1mM. 
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3.1.4 Effect on cell viability, ATP and DNA proliferation 
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Fig.12. The effects of 24 hr nicotine exposure on cell viability, ATP 
and DNA proliferation. 
 
Fig. 12 shows that nicotine in MCF-7 breast carcinoma cells at 24 hrs, resulted in 
unaffected % viability and ATP levels while DNA proliferation was significantly 
elevated significantly above 100% at all concentrations.  
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Fig. 13. The effects of 48 hr exposed MCF-7 cells to selected nicotine 
concentrations. 
 
Fig.13 depicts the effects of nicotine after 48 hrs of exposure on MCF-7 cells. ATP 
activity and DNA proliferation remained consistently high even though viability had 
decreased between 0.1 and 1 µM.  
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Fig. 14. The effect of nicotine induced MCF-7 cells after 72 hrs. 
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Fig. 14 indicates that viability and ATP activity remained the same after 72 hrs at all 
concentrations of nicotine, while, DNA proliferation increased and remained above 140% 
after 0.001 µM.  
3.1.5 Early apoptotic effects on MCF-7 cells 
Table 10: The effect of selected nicotine concentrations on early apoptosis in 
MCF-7 cells after 24 hrs of exposure (20 000 events analysed)  
Concentration  
(µM) 
Percentage 
Dead Cells 
Dead 
Apoptotic 
Cells 
Live Cells 
Early 
Apoptotic 
Cells 
0 0.02 0.01 99.91 0.06 
0.0001 0.09 0.53 98.24 1.15 
0.001 0.77 0.77 95.58 2.89 
0.01 0.09 0.66 98.31 0.93 
0.1 0.1 0.59 98.19 1.12 
1 0.07 0.54 98.16 1.23 
 
Table 10 demonstrates that dead cell population, early apoptotic cells and dead apoptotic 
cells were unaffected. The % live cell populations obtained after 24 hrs, treated with 
nicotine, were unaffected at all concentrations when compared to controls.  
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Table 11: The effect of selected nicotine concentrations on early apoptosis in 
MCF-7 cells after 48 hrs of exposure (20 000 events analysed) 
Concentration 
(µM) 
Percentage 
Dead Cells 
Dead 
Apoptotic 
Cells 
Live Cells 
Early 
Apoptotic 
Cells 
0 0.02 0.01 99.91 0.06 
0.0001 0.35 1.6 95.83 2.22 
0.001 0.55 1.42 96.48 1.55 
0.01 1.09 2.3 94.96 1.65 
0.1 0.35 1.81 95.19 2.65 
1 0.5 1.63 95.42 2.45 
 
Table 11 shows that nicotine after 48 hrs of exposure, did not result in changes in the 
number of early apoptotic cells. MCF-7 cells exposed to any nicotine concentration 
analysed were similar to controls.  
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Table 12: The effect of selected nicotine concentrations on apoptosis in MCF-7 
cells after 72 hrs of exposure (20 000 events analysed) 
Concentration 
(µM) 
Percentage 
Dead Cells Dead Apoptotic Cells Live Cells 
Early 
Apoptotic Cells
0 0.02 0.01 99.91 0.06 
0.0001 1.22 4.00 92.27 2.51 
0.001 0.94 3.6 92.11 3.35 
0.01 1.29 5.92 89.07 3.72 
0.1 1.9 4.12 90.87 3.11 
1 1.7 2.75 93.19 2.37 
 
Table 12 demonstrated no differences in apoptotic and dead cell numbers at all 
concentrations. Thus, after 72 hrs, cells remain unaffected relative to control. 
 
 
 
Fig. 15. Scatter plots created from the flow cytometry analysis represent the controls used 
for comparison of the effects of Nicotine at a) Unstained MCF-7 cells, b) PI 
only stained MCF-7 cells and c) staurosporine treated, annexin V only stained 
MCF-7 cells (positive control). 
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Fig. 16. Scatter plots obtained from flow cytometry analysis depict the effect of 0.1 nM 
of Nicotine on MCF-7 cells at a) 24, b) 48 and c) 72 hrs. 
 
 
 
Fig. 17. The effects of 0.1 nM Nicotine on MCF-7 cells (data obtained from flow 
cytometry scatter plots). 
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Fig. 18. Scatter plots displaying the effects of 1 nM Nicotine at a) 24 hrs, b) 48 hrs and c) 
72 hrs. 
 
 
Fig. 19. The effects of 1 nM Nicotine on MCF-7 cells. 
 
 
Fig. 20. Scatter plots illustrating the effects of 0.01 µM Nicotine on MCF-7 cell at a) 24 
hrs, b) 48 hrs and c) 72 hrs. 
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Fig. 21. The effects of 0.01 µM Nicotine on MCF-7 cells. 
 
 
Fig. 22. Scatter plots displaying the effects of 0.1 µM Nicotine on MCF-7 cells at a) 24 
hrs, b) 48 hrs and c) 72 hrs. 
 
 
 
Fig. 23. The effects of 0.1 µM Nicotine on MCF-7 cells. 
 
 
 
 
44 
 
 
Fig. 24. Scatter plots depicting the effects of 1 µM Nicotine on MCF-7 cells at a) 24 hrs, 
b) 48 hrs and c) 72 hrs. 
 
 
 
Fig. 25. The effects of 1 µM Nicotine on MCF-7 cells. 
 
Scatter plots and pie charts (Fig. 15 to 25) illustrate the effects of selected concentrations 
of Nicotine on early apoptosis in MCF-7 cells. Flow cytometry analysis showed that 
Nicotine did not significantly alter the early apoptotic cell population at any selected 
concentration or time intervals. 
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3.2 Effect of Tunicamycin on MCF-7 cells 
3.2.1 Effect on cell viability 
Table 13: The effect of selected tunicamycin concentrations on MCF-7 cell 
viability (Mean ± SEM) 
Concentration 
(µM) 24 Hour 48 Hour 72 Hour 
0.0001 94.788 ± 0.51 91.340 ± 0.712 108.715 ± 3.159 
0.001 91.057 ± 1.132 91.924 ± 1.614 103.166 ± 3.137 
0.0039 76.382  ± 3.07 76.362 ± 3.070 129.014 ± 2.540 
0.0078 67.101 ± 6.257 77.662 ± 9.643 111.508 ± 2.996 
0.01 69.884 ± 1.114 69.581 ± 3.743 85.584 ± 1.113 
0.0156 60.418 ± 4.621 59.101 ± 5.220 85.693 ± 2.231 
0.03125 57.512 ± 2.705 44.356 ± 2.628 56.272 ± 3.324 
0.0625 53.117 ± 0.872 43.797 ± 1.731 40.302 ± 2.494 
0.1 53.636 ± 1.252 36.489 ± 5.940 10.490 ± 1.758 
0.125 55.538 ± 1.590 13.985 ± 1.313 8.258 ± 1.020 
0.25 47.841 ± 1.601 13.904 ± 1.012 6.639 ± 1.197 
0.5 44.589 ± 0.933 11.959 ± 0.989 6.477 ± 0.999 
1 46.180 ± 0.918 10.857 ± 0.765 7.116 ± 0.586 
 
Table 13 shows the effects of Tm on MCF-7 % viability. As Tm concentrations increased 
for all incubation periods, viability decreased. % viability significantly decreased by 
48.61% (p=0.0004) and 80.48% (p=0.0159) and 101.604% (p=0.0011) at 24, 48 and 72 
hrs, between 0.1 nM and 1 µM respectively. The viability of MCF-7 cell was unaffected 
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at the lower concentrations between 0.0001 µM and 0.0078 µM for all incubation times. 
Cells incubated for 72 hrs with 0.1 µM Tm displayed a significantly reduced viability 
(p=0.0043) when compared to the viability at 24 hrs. The % viability remained notably 
higher at 24 hrs for 0.125, 0.25, 0.5 and 1 µM when compared to the 48 and 72 hr 
viability. 
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Fig. 26 illustrates the effects of various Tm concentrations on MCF -7 cell viability at 24, 
48 and 72 hrs. Marked differences were observed between highest and lowest 
concentration of 0.1 nM and 1 µM at, 24 hrs (p=0.0004), 48 hrs (p=0.0159) and 72 hrs 
(p=0.0011). Significant differences was only observed when comparing 0.0078 µM for 
24 and 72 hrs (p=0.0159) and 48 and 72 hrs (p=0.0079). MCF-7 cells displayed a gradual 
decrease in viability for 24 hrs as the Tm concentration increased. The cells % viability 
trend at 48 hrs was similar to that of cells incubated for 24 hrs, however at 0.125 µM 
there was a significant decrease in viability when compared to the 24 hr-incubated cells, 
Fig.26. Effects of various tunicamycin concentrations on MCF-7 cells viability.  
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which continued with exposure to the subsequent higher concentrations. Cells incubated 
for 72 hrs (from 0.0001 µM to 0.0156 µM) also displayed similar trends to 24 and 48 hr-
incubated cells, however at higher concentrations of 0.125 µM there was a noticeable 
decrease in viability, which thereafter continued similarly to that of the viability of cells 
incubated for 48 hrs. % viability at 24 hr-exposed cells did not go below ±46%.  
3.2.2 Effect on ATP production 
 
Table 14:  The effect of selected tunicamycin concentrations on ATP production 
in MCF-7 cells (Mean ± SEM) 
 Concentration 
(µM) 24 Hour 48 Hour 72 Hour 
0.25  53.663 ± 0.725 35.516 ± 0.989 22.015 ± 0.546 
0.5  64.748 ± 0.775 38.020 ± 2.347 13.596 ± 0.137 
1 66.158 ± 0.920 33.021 ± 0.826 7.471 ± 0.191 
1.5  66.511 ± 0.767 32.738 ± 0.879 6.224 ± 0.370 
2 68.527 ± 1.071 34.154 ± 1.328 10.831 ± 0.423 
 
Table 14 shows the differences in ATP production observed when cells were treated to 
selected concentrations at 24, 48 and 72 hrs. Statistical differences were observed 
between 24 and 48 hrs, between 48 and 72 hrs as well as 24 and 72 hrs at all 
concentrations of Tm used (p≤0.005).   
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Fig. 27. The effects of selected tunicamycin concentrations on ATP production. 
 
Fig. 27 shows the effects of selected Tm concentrations on the % ATP production of 
MCF-7 cells at various time periods. ATP production was significantly higher (p≤0.0001) 
for all Tm concentrations at 24 hrs when compared to 48 and 72 hrs. The cells displayed 
similar % ATP production trends for 24, 48 and 72 hrs between 0.25 and 2 µM, although 
at significantly lower ATP levels, with the lowest ATP levels observed at 72 hrs. 
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3.2.3 Effect on DNA proliferation  
Table 15: The effect of selected tunicamycin concentrations on DNA 
proliferation in MCF-7 cells (Mean ± SEM) 
Concentration 
(µM) 
 
24 Hour 48 Hour 72 Hour 
0.25 25.930 ± 1.353 105.435 ± 2.267 241.450 ± 11.5153 
0.5 26.345 ± 3.529 121.750 ± 4.268 241.948 ± 6.156 
1 27.600 ± 2.628 116.090 ± 13.618 231.028 ± 19.386 
1.5 26.513 ± 1.870 129.550 ± 11.113 221.305 ± 4.048 
2 28.023 ± 1.441 138.148 ± 2.506 227.065 ± 8.386 
 
The effects of selected Tm concentrations over 24, 48 and 72 hrs are shown in Table 15. 
For all selected concentrations a significant increase was noted (p≤0.0286) between 24 
and 48 hrs, 48 and 72 hrs and 24 and 72 hrs.  
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Fig. 28. The effect of selected Tm concentrations on DNA proliferation in MCF-7 cells 
at 24, 48 and 72 hrs. 
 
Fig. 28 shows the effect of the selected Tm concentrations on DNA proliferation in MCF-
7 cells at 24, 48 and 72 hrs. The effect of Tm remained the same at 24 hrs at any of the 
concentrations used. Similar trends were observed at 48 hr and 72 hrs, although the % of 
DNA proliferation was markedly higher (p≤0.0286) when compared to 24 hrs, with the 
highest proliferation observed at 72 hrs.   
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3.2.4 Effect on cell viability, ATP and DNA proliferation 
1
0
20
40
60
80
Viability
ATP
Proliferation
Concentration (M)
%
 
Fig. 29. The effects of 24 hr tunicamycin exposure on cell viability, ATP activity and 
DNA proliferation. 
 
Cell viability decreased gradually between 1 nM and 1 µM at 24 hrs (Fig. 29). ATP 
production was greater in % than cell viability, and DNA proliferation was suppressed at 
these concentrations at 24 hrs. 
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Fig. 30. The effectof tunicamycin treated MCF-7 cells after 48 hr. 
 
Fig. 30 exhibits the effect of Tm concentrations after 48 hrs on viability, ATP and DNA 
proliferation. The graph shows that viability and ATP productions were considerably 
suppressed. However, DNA proliferation had exceeded 100% and augmented as 
concentrations of Tm increased. 
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Fig. 31. The effect of tunicamycin induced MCF-7 cells after 72 hrs. 
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Fig. 31 demonstrates the effects of Tm on MCF-7 cells after 72 hrs. Viability and ATP 
productions were below 20%. A dramatic average of 230% in DNA proliferation was 
observed after 72 hrs of exposure for all concentrations. 
 
3.2.5 Early apoptotic effects on MCF-7 cells 
Table 16: The effect of selected tunicamycin concentrations on early apoptosis in 
MCF-7 cells after 24 hrs of exposure (20 000 events analysed) 
Concentration 
(µM) 
Percentage 
Dead Cells 
Dead 
Apoptotic 
Cells 
Live Cells 
Early 
Apoptotic 
Cells 
0 0.02 0.01 99.91 0.06 
0.25 0.59 10.19 72.51 16.7 
0.5 0.79 13.74 69.02 16.46 
1 0.51 11.42 71.47 16.6 
1.5 0.58 12.29 68.99 18.15 
2 0.05 12.70 70.80 16.50 
 
Table 16 shows the early apoptotic effects of Tm at selected concentrations on MCF-7 
cells after 24 hrs. All concentrations of Tm exposure resulted in, early apoptotic cells that 
were below 18.15%. The population of live cells were above 68.99% with less than 0.8% 
dead cell population.  
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Table 17:   The effect of selected tunicamycin concentrations on early apoptosis in 
MCF-7 cells after 48 hrs of exposure (20 000 events analysed) 
Concentration 
(µM) 
Percentage 
Dead Cells 
Dead 
Apoptotic 
Cells 
Live Cells 
Early 
Apoptotic 
Cells 
0 0.02 0.01 99.91 0.06 
0.25 22.91 61.58 5.83 9.69 
0.5 12.98 61.82 7.93 17.27 
1 17.49 66.8 4.31 11.4 
1.5 13.6 62.03 5.23 19.14 
2 8.9 72.65 2.92 15.53 
 
Table 17 shows the apoptotic phases of MCF-7 cells induced with various Tm 
concentrations after 48 hrs. More than 61% of the population at all concentrations were 
dead due to apoptosis after 48 hrs. The % of live cells for all concentrations, were below 
10%. 
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Table 18:    The effect of selected tunicamycin concentrations on early apoptosis in 
MCF-7 cells after 72 hrs of exposure (20 000 events analysed) 
Concentration 
(µM) 
Percentage 
Dead Cells 
Dead 
Apoptotic Cells Live Cells 
Early 
Apoptotic Cells
0 0.02 0.01 99.91 0.06 
0.25 16.33 44.02 4.7 34.95 
0.5 11.8 35.27 8.36 44.57 
1 15.04 46.91 2.68 35.38 
1.5 16.17 48.7 2.19 32.94 
2 11.5 41.06 3.72 43.72 
 
Table 18 shows the early apoptotic effects after 72 hrs when MCF-7 cells were exposed 
to selected Tm concentrations. Populations representing dead apoptotic cells were similar 
to those of the early apoptotic phase.  
 
 
 
Fig. 32. The scatter plots created from the flow cytometry analysis represent the controls 
used for comparison of the effects of tunicamycin, a) Unstained MCF-7 cells, b) 
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PI only stained MCF-7 cells and c) staurosporine treated, annexin V only stained 
MCF-7 cells (positive control). 
 
 
 
Fig. 33. Scatter plots represent the effects of 0.25 µM Tm on early apoptosis in MCF-7 
cells at a) 24 hrs, b) 48 hrs and c) 72 hrs. 
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Fig. 34. The effects of 0.25 µM Tm on early apoptosis in MCF-7 cells. 
 
Fig. 33 and 34 shows that 0.25 µM Tm at 24 hrs, resulted in 72.51% of live cells and 
16.7% undergoing early apoptosis. However, after 48 hrs, only 5.83% of the cells were 
alive and 61.58% of the cell population were dead due to apoptosis. After 72 hrs, 34.95% 
of the population was in early apoptosis compared to 9.69% after 48 hrs of incubation.  
 
 
Fig. 35. Scatter plots displaying effects of 0.5 µM Tm on MCF-7 cells at a) 24 hrs, b) 48 
hrs and c) 72 hrs. 
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Fig. 36. The effects of 0.5 µM Tm on early apoptosis in MCF-7 cells. 
 
Fig. 35 and 36 illustrates the effects of 0.5 µM of Tm on MCF-7 cells at the selected time 
intervals. At 24 hrs, 69% of the cell population was alive, and decreased to 12.98 % and 
11.8% at 48 and 72 hrs respectively. Cells undergoing early apoptosis were similar at 24 
hrs (16.46%) when compared to 48 hrs (17.27%). At 72 hrs early apoptotic cells had 
increased to 44.57%.  
 
 
Fig. 37. The apoptotic effects of 1 µM Tm on MCF-7 cells at a) 24 hrs, b) 48 hrs and c) 
72 hrs. 
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Fig. 38. The effects of 1 µM Tm on MCF-7 cells. 
 
Fig. 37 and 38 displays a decline of 65.16% in live cell population between 24 and 48 
hrs. There were similar early apoptotic populations with a 55.38% increase in dead 
apoptotic cells.  An increase of 24% was observed between 48 and 72 hrs for early 
apoptotic cells, while dead apoptotic cell population decreased by 19.9%  
 
 
Fig. 39. Scatter plots of the apoptotic effects of 1.5 µM Tm on MCF-7 cells at a)24 hrs, 
b) 48 hrs and c) 72 hrs. 
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Fig. 40. The effects of 1.5 µM Tm on MCF-7 cells. 
 
1.5 µM Tm resulted in a 63.76% decrease in live cell population between 24 and 48 hrs, 
while the dead apoptotic cell population increased by 50.74% (Fig. 39 and 40). The 
population of early apoptotic cells increased from 19.14 to 32.94% between 48 and 72 hrs 
and the dead apoptotic cell population decreased from 62.03% to 48.7%.  
 
 
Fig. 41. Scatter plots of the effects of 2 µM Tm on MCF-7 cells a) 24 hrs, b) 48 hrs and 
c) 72 hrs. 
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Fig. 42. The effects of 2 µM Tm on MCF-7 cells. 
 
Fig. 41 and 42 illustrates that 2 µM of Tm resulted in a 91.43% decrease in live cells 
between 24 and 72 hrs. Early apoptotic cell population increased by 41.62% and dead 
apoptotic cells increased from 2.7% to 41.06%.    
 
Overall (Fig. 33 to Fig. 42) data showed that 24 hr exposure to Tm resulted in live cell 
populations above 69%. At 72 hrs this population decreased to a maximum of 48.7%. 
Dead apoptotic cells increased between 24 and 48 hrs and decreased between 48 and 72 
hrs. At 24 hrs the dead apoptotic cells never exceeded 13.74% and the early apoptotic 
cells never exceeded 18.15%. However, at 48 hrs the dead apoptotic cells ranged between 
61.58 and 72.62% compared to the 9.69 and 19.14% range for early apoptotic cells. At 72 
hrs the dead apoptotic cells (35.27 to 48.7%) were similar to the early apoptotic cells 
(32.94 to 44.57%). 
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3.3 The effect of Thapsigargin on MCF-7 cells 
3.3.1 Effect on cell viability 
 
Table 19: The effect of selected thapsigargin concentrations on MCF-7 cell 
viability (Mean ± SEM)  
Concentration 
(µM) 24 Hour 48 Hour 72 Hour 
0.0001 124.121 ± 3.552 122.066 ± 1.988 125.192 ± 5.787 
0.001 115.036 ± 6.058 116.588 ± 4.860 113.563 ± 3.418 
0.01 60.383 ± 2.315 109.692 ± 3.203 116.827 ± 4.663 
0.0125 81.798 ± 2.339 77.540 ± 3.340 124.725 ± 7.442 
0.025 50.440 ± 3.721 61.790 ± 1.418 87.414 ± 2.461 
0.05 46.814 ± 2.285 27.707 ± 2.818 45.737 ± 1.752 
0.1 41.340 ± 2.793 19.007 ± 0.555 10.154 ± 0.997 
0.2 40.266 ± 2.005 17.404 ± 0.574 5.093 ± 1.266 
0.3 40.044 ± 2.167 20.008 ± 1.446 4.109 ± 2.729 
0.4 36.198 ± 1.512 16.266 ± 1.348 2.079 ± 1.194 
0.8 31.3677 ± 1.842 10.216 ± 1.654 2.999 ± 1.878 
1 44.586 ± 4.057 23.554 ± 2.359 3.145 ± 0.386 
 
Results obtained (Table 19) shows that the lowest concentration of Tg (0.1 nM and 
0.001 µM) resulted in similar effects on % viability at the selected time intervals. 
Overall, Tg exposure resulted in a significant decrease (p≤0.001) in % viability when 
comparing the effects at the highest Tg concentration of 1 µM to the lowest of 0.1 nM 
at 24, 48 and 72 hrs (p≤0.01). The cells displayed greater viability at 72 hrs between 
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0.1 nM and 0.025 µM when compared to the 24 hr-exposed cells. However, the MCF-
7 cells displayed noticeably (p<0.05) lower viability at 48 and 72 hrs between 0.1 µM 
and 1 µM when compared to the 24 hr incubation time.  
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Fig. 43. The effect of various concentrations of thapsigargin on MCF-7 cell viability. 
Fig. 43 shows the effect of various concentrations of Tg on MCF-7 viability. A 
statistical difference was observed between 0.1 nM and 1 µM for all time intervals. 
The trends were similar when comparing the incubation times. % viability was similar 
at 0.1 nM for all time periods; however it was evident that viability was significantly 
different between 0.1 nM (p=0.0044) and 1 µM (p=0.0044) for each time period. Cell 
viability were significant at 1 µM between 24 and 48 hrs (p=0.0022), 48 and 72 hrs 
(p=0.0055) and between 24 and 72 (p=0.0021). 
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3.3.2 Effect on ATP production  
Table 20: The effect of selected thapsigargin concentrations on ATP production 
in MCF-7 cells (Mean ± SEM) 
Concentration 
(µM) 
24 Hour 48 Hour 72 Hour 
0.05 61.891 ± 1.280 61.178 ± 0.796 71.289 ± 2.789 
0.1 52.417 ± 2.947 34.778 ± 0.887 17.243 ± 0.923 
0.2 56.634 ± 1.456 23.186 ± 0.646 8.757 ± 0.696 
0.3 56.704 ± 1.033 20.294 ± 0.503 4.925 ± 0.182 
0.4 59.343 ± 1.344 20.658 ± 1.066 6.869 ± 0.611 
 
Table 20 shows that ATP concentrations at 0.05 µM, was similar at all incubation 
times. No difference was observed between 0.05 and 0.4 µM at 24 hrs. However, at 
48 and 72 hrs (between 0.05 µM to 0.4 µM) difference (p≤0.009) was observed.  A 
decrease of 40.52% in ATP production was evident from 0.1 µM to 0.4 µM at 48 hrs 
and a decline of 64.42% at 72 hrs. 
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Fig. 44. The effect of selected Tg concentrations on ATP production of 
MCF -7 cells. 
 
Fig. 44 illustrates that as time increases, ATP production decreased at all 
concentrations of Tg analysed. While 24 hrs ATP concentrations was similar, both 48 
and 72 hr levels displayed the same declining trend with the latter displaying lower 
concentrations than the former (p≤0.009) 
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3.3.3  Effect on DNA proliferation  
Table 21: The effect of various concentrations of thapsigargin on DNA 
proliferation in MCF -7 cells (Mean ± SEM) 
Concentration 
(µM) 
24 Hour 48 Hour 72 Hour 
0.05 19.568 ± 3.284 130.577 ± 13.215 208.320 ± 9.9338 
0.1 17.208 ± 1.547 139.925 ± 5.695 210.860 ± 7.8548 
0.2 15.858 ± 1.393 143.355 ± 7.087 180.470 ± 13.910 
0.3 15.160 ± 1.012 161.933 ± 5.061 204.213 ± 6.249 
0.4 13.428 ± 2.093 150.298 ± 6.615 204.880 ± 7.173 
 
Table 21, shows that DNA proliferation did not exceed 19.57% at 24 hrs, however 
after 48 hrs, proliferation exceeded 130.56% and at 72 hrs, it reached 210.86% at 0.1 
µM. No differences were observed between 0.05 µM and 0.4 µM at 24, 48 and 72 hrs. 
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Fig. 45. The effect of selected Tg concentrations on DNA proliferation of MCF-7 
cells.  
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Fig. 45 demonstrates that DNA proliferation, after 72 hrs was above 180%, 
significantly higher than at 24 or 48 hrs (p≤0.0286) for all concentrations. The 
proliferation at 48 hrs was markedly higher that at 24 hrs at all concentrations of Tg.  
 
3.3.4 Effect on cell viability, ATP and DNA proliferation 
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Fig. 46. The effect of Tg after 24 hrs of exposure on viability, ATP and DNA        
proliferation. 
 
At 24 hrs, a range of 52.42 to 61.89% ATP was observed, with viability levels lower 
than 46.81% and DNA proliferation not exceeding 19.57%.   
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Fig. 47. The effect of Tg after 48 hrs of exposure on viability, ATP and DNA      
proliferation. 
 
Fig. 47 indicated that viability did not exceed 27.7% at 48 hrs. MCF-7 cells displayed 
an ATP production of 61.18% at 0.05 µM. A significant decrease in ATP was 
observed at 0.4 µM and remained the same for the lower Tg concentrations. DNA 
proliferation was significantly high ranging between 130.58% and 161.9%.  
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Fig. 48. The effect of select Tg concentrations after 72 hrs of exposure on 
viability, ATP activity and DNA proliferation. 
 
Fig. 48 shows that levels of viability did not exceed 45.7% after 72 hrs. The cells 
displayed an ATP production of 71.28% at 0.05 µM. A significant decrease in ATP 
was observed at 0.1 µM with increasing Tg concentrations. DNA proliferation at 72 
hrs ranged between was 180.47% and 210.8%. 
  
0.05                    .                         0.2            0.3       0.4 
 
 
 
 
70 
 
3.3.5 Early apoptotic effects on MCF-7 cells 
Table 22: The apoptotic effects of selected thapsigargin concentrations at 24 hr 
exposure in MCF-7 cells (20 000 events analysed) 
Concentration 
(µM) Dead Cells 
Dead 
Apoptotic 
Cells 
Live Cells 
Early 
Apoptotic 
Cells 
0 0.02 0.01 99.91 0.06 
0.05 0.59 8.21 81.88 9.32 
0.1 0.88 7.58 83.17 8.38 
0.2 0.08 3.74 92.97 3.21 
0.3 1.07 10.03 79.49 9.42 
0.4 2.27 34.73 24.21 38.79 
 
Table 22 shows that an increase in dead apoptotic cells between 0.05 and 0.4 µM. 
Similarly, an increase in early apoptotic cells were noted and a decline in live cells 
compared to the subsequent lower concentrations. Overall, MCF-7 cells were 
unaffected between 0.05 µM and 0.3 µM. 
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Table 23: The apoptotic effects of selected thapsigargin concentrations at 48 
hr exposure on MCF-7 cells (20 000 events analysed) 
Concentration 
(µM) Dead Cells 
Dead 
Apoptotic 
Cells 
Live Cells 
Early 
Apoptotic 
Cells 
0 0.02 0.01 99.91 0.06 
0.05 8.19 51.26 24.34 16.21 
0.1 35.94 36.54 19.23 8.29 
0.2 11.18 67.41 8.69 12.72 
0.3 9.57 68.66 9.76 12.01 
0.4 10.66 67.74 8.07 13.54 
 
Table 23 illustrates that as concentrations increased live cell numbers decreased. 
Similarly, a trend between concentrations and their effect on dead apoptotic cells was 
also observed except at 0.1 µM where an increase in dead cells was observed. 
Generally, more dead cells as a result of apoptosis was observed at 48 hrs, when 
compared to early apoptotic cells.  
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Table 24: The apoptotic effects of selected thapsigargin concentrations at 72 
hrs exposure in MCF-7 cells (20 000 events analysed) 
Concentration 
(µM) Dead Cells 
Dead 
Apoptotic 
Cells 
Live Cells 
Early 
Apoptotic 
Cells 
0 0.02 0.01 99.91 0.06 
0.05 9.37 36.38 31.02 23.23 
0.1 16.11 41.34 3.82 38.73 
0.2 17.91 45.2 1.35 35.54 
0.3 11.41 46.48 1.01 41.1 
0.4 15.82 45.34 2.16 36.69 
 
Table 24 shows that at 72 hrs, dead apoptotic cells exposed to 0.05 µM to 0.4 µM Tg 
was 36.38% to 45.34% respectively. The early apoptotic cell population ranged 
between 23.23% and 41.1% for the same concentration range. The dead cell 
population did not exceed 17.91%. 
 
 
Fig. 49. The scatter plots created from the flow cytometry analysis represent 
the controls used for comparison of the effects of Thapsigargin. a) 
Unstained MCF-7 cells b) PI only stained MCF-7 cells and c) 
staurosporine treated, annexin V only stained MCF-7 cells (positive 
control). 
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Fig. 50. Scatter plots representing the effect of 0.05 µM Tg at a) 24 hrs, b) 48 
hrs and c) 72 hrs. 
 
 
Fig. 51. pie charts indicating the effect of 0.05 µM Tg at      various time 
intervals. 
 
Early apoptotic population increased from 9.32% to 23.23% from 24 to 72 hrs when 
exposed to 0.05 µM Tg (Fig.50 and 51).  At 24 hrs, live cell population was 81% and 
at 48 and 72 hrs the population did not exceed 31.02%. Between 24 and 48 hrs, there 
was an increase of 43.05% in cells dead due to apoptosis which declined by 14.88% 
after 72 hrs. 
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Fig. 52. Scatter plots illustrated apoptotic effects of 0.1 µM Tg at a) 24 hrs, b) 
48 hrs and c) 72 hrs. 
 
 
Fig. 53. The apoptotic effects of 0.1 µM Tg.  
 
Fig. 52 and 53 show an increase of 30.35% in early apoptotic cells, and 33.76% in 
cells dead due to apoptosis between 24 and 72 hrs. Live cells exposed to 0.1 µM Tg 
decreased by 79.35% for the same time interval. 
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Fig. 54. Scatter plots displaying the effects of 0.2 µM Tg on MCF-7 cells at a) 24 hrs, 
b) 48 hrs and c) 72 hrs. 
 
 
Fig. 55. The apoptotic effects of 0.2 µM Tg. 
 
Fig. 54 and 55 demonstrates that 92.97% of cells after 24 hrs were still alive and 
significantly decreased by 91.62% after 72 hrs. Furthermore, as time increased early 
apoptotic population increased by 32.33% and the amount of dead apoptotic cells 
increased by 41.46%.  
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Fig. 56. Scatter plots showing the effects of 0.3 µM Tg on MCF-7 cells at a) 24 hrs, 
b) 48 hrs and c) 72 hrs. 
 
Fig. 57. The apoptotic effects of 0.3 µM Tg. 
 
Fig. 56 and 57 show that, dead apoptotic cells increased by 58.63%, between 24 and 
48 hrs, while all other populations were similar. The dead apoptotic cell population 
decreased by 22.18% between 48 and 72 hrs, with the early apoptotic cells displaying 
similar levels. 
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Fig. 58. Scatter plots representing the effect of 0.4 µM Tg on MCF-7 cells at a) 24 
hrs, b) 48 hrs and c) 72 hrs. 
 
Fig. 59. The apoptotic effects of 0.4 µM Tg. 
 
Fig. 58 and 59 showed an increase in dead apoptotic cells observed between 24 and 
48 hrs, followed by a decrease at 72 hrs. While early apoptotic populations decreased 
at 48 hrs, followed by an increase at 72 hrs.  
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3.4 The combinatorial effect of Tunicamycin and Nicotine on MCF-7 cells 
3.4.1 Effect on cell viability 
 
Table 25: The effect of combinations (ratio 1:1) of selected tunicamycin and 
nicotine concentrations on MCF-7 cell viability (Mean ± SEM) 
Concentration 
(µM) 24 Hour 48 Hour 72 Hour 
0.0001 
73.040 ± 6.439 64.234 ± 2.823 69.963 ± 2.645 
0.001 
66.921 ± 2.663 48.683 ± 1.370 53.154 ± 1.286 
0.01 
66.016 ± 4.035 45.901 ± 0.576 51.199 ± 1.658 
0.1 
56.707 ± 1.912 32.945 ± 4.209 37.902 ± 2.967 
1 
56.696 ± 3.099 27.561 ± 1.959 27.563 ± 2.421 
10 
56.63 ± 2.546 26.878 ± 2.002 28.251 ± 3.306 
100 
43.865 ± 2.358 22.133 ± 3.317 22.223 ± 1.318 
200 
12.485 ± 1.252 9.835 ± 0.384 8.580 ± 1.148 
300 
7.956 ± 0.862 11.794 ± 0.779 1.217 ± 0.991 
 
Table 25 shows that % viability significantly decreased between 0.1 nM and 300 µM 
at 24, 48 and 72 hrs (p<0.05). At 0.1, 1, 10, and 100 µM of 1:1 ratio of Tm:Nic, 
viability was noticeably lower at 48 and 72 hrs when compared to 24 hrs. 
 
 
 
 
79 
 
0.0001 0.001 0.01 0.1 1 10 100 1000
0
20
40
60
80
100
24H
48 H
72 H
Concentration (M)
%
 V
ia
bi
li
ty
 
Fig. 60. Effects of various Tm:Nic combinations on MCF-7 cells viability.  
 
% viability was similar between 0.1 nM and 10 µM at 24 hrs. Fig. 60 shows that, at 
the subsequent concentrations, viability decreased significantly between 10 µM and 
300 µM (p<0.0043). The trend observed at 48 and 72 hrs, were similar between 0.1 
nM and 300 µM, decreasing (p<0.0043) by 20.451% and 36.685%, respectively. 
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3.4.2 Effect on ATP production  
 
Table 26: The effect of combinations (ratio 1:1) of selected tunicamycin and 
nicotine concentrations on ATP production in MCF-7 cells (Mean ± 
SEM) 
Concentration 
(µM) 
24 Hour 48 Hour 72 Hour 
0.01 100.707 ± 1.9 95.545 ± 1.055 89.443 ± 0.770 
0.1 77.35 ± 1.969 20.36 ± 0.435 19.368 ± 1.326 
1 66.137 ± 1.196 9.119 ± 0.199 4.495 ± 0.147 
 
Table 26 displays the effect of Tm:Nic combinations on ATP production at the 
selected concentrations and time intervals. As concentrations increased from 0.01 to 1 
µM, % ATP production significantly decreased (p≤0.0286), by 34.58%, 86.43% and 
84.94% respectively. 
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Fig. 61. The effects of selected combinations (ratio 1:1) of Tm:Nic 
concentrations on ATP production. 
Fig. 61 shows that the 1:1 ratio combination of Tm:Nic on ATP production in MCF-7 
cells were above 66% at 24 hrs at the highest concentration of 1 µM. Cellular energy 
levels were greatly inhibited thereafter with (p≤0.0286) at 48 and 72 hrs. It also 
illustrated similar trends between 24, 48 and 72 hrs with their steep decline in ATP 
production. 
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3.4.3  Effect on DNA proliferation  
Table 27: The effect of combinations (ratio 1:1) of selected tunicamycin and  
nicotine concentrations on DNA proliferation in MCF-7 cells (Mean 
± SEM) 
Concentration 
(µM) 
24 Hour 48 Hour 72 Hour 
0.01 63.133 ± 2.448 49.788 ± 2.327 116.120 ± 9.941 
0.1 21.400 ± 1.635 85.595 ± 10.736 218.383 ± 16.686 
1 25.105 ± 1.625 98.955 ± 1.989 264.133 ± 7.949 
 
Table 27 shows that, DNA proliferation in MCF-7 cells at 24 hrs significantly 
(p<0.05) decreased between 0.01 and 0.1 µM ratios. However, after 48 hrs DNA 
proliferation noticeably increased (p=0.0286) between 0.01 and 0.1 µM.  DNA 
proliferation decreased, by 38.03% after 24 hrs between 0.01 and 1 µM, in 
comparison to the increase of 148.01% after 72 hrs. 
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Fig. 62. The effect of selected Tm:Nic (1:1) ratio concentrations on DNA 
proliferation of MCF-7 cells at 24, 48 and 72 hrs. 
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MCF-7 cells induced with combinations of the selected Tm:Nic (1:1 ratio) 
concentrations, (Fig. 62) at 24 hrs, displayed a marked decrease (p=0.0286) in DNA 
proliferation while at 48 hrs and 72 hrs, % proliferation was elevated. The trend 
observed at 72 hrs was at significantly higher levels when compared to 48 or 24 hrs. 
3.4.4 Effect on cell viability, ATP and DNA proliferation 
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Fig. 63. The 24 hr effects of the combination Tm:Nic (1:1) ratio on viability, 
ATP and DNA proliferation. 
Fig. 63 illustrates that viability remained similar at the concentrations analysed. ATP 
levels significantly decreased and reached 66.137% at 1 µM with % viability at 56.7% 
for the same concentration. DNA proliferation at 0.01 µM was similar to % viability, 
but was significantly decreased at 0.1 and 1 µM. 
 
 
 
 
84 
 
0.01 0.1 1
0
20
40
60
80
100
120
140 Viability
ATP
Proliferation
Concentration (M)
%
 
Fig. 64. The effects 48 hrs exposed MCF-7 cells to selected Tm:Nic (1:1) ratio  
concentrations. 
 
At 48 hrs of Tm:Nic combinations, as depicted in Fig. 64, viability decreased from 
45.901% to 27.56%. ATP production markedly declined as DNA synthesis 
significantly increased as the concentration of the combinations increased. 
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Fig. 65. The effect of Tm:Nic (1:1) ratio induced MCF-7 cells after 72 hrs. 
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Fig. 65 displays the effects of the 1:1 combination after 72 hrs. % viability 
and ATP production steadily decreased with the increase in concentration. 
DNA synthesis rose significantly between 0.01 and1 µM 1:1 ratio. 
3.4.5 Early apoptotic effects on MCF-7 cells  
 Table 28: The effect of combination (1:1 ratio) of selected tunicamycin 
and nicotine concentrations on early apoptosis in MCF-7 
cells after 24 hrs of exposure (20 000 events analysed) 
Concentration 
(µM) Dead Cells 
Dead 
Apoptotic 
Cells 
Live Cells 
Early 
Apoptotic 
Cells 
0 0.02 0.01 99.91 0.06 
0.01 0.08 2.65 93.03 4.23 
0.1 0.45 9.8 75.54 14.22 
1 1.35 12.49 66.08 20.07 
 
Table 28 shows the effect on early apoptosis of the 1:1 ratio of Tm:Nic combination 
after 24 hrs. Early apoptotic cell population increased by 20.07% at 1 µM when 
compared to control.  The live cell population decreased by 16.95% between 0.01 and 
1 µM 
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Table 29:   The effect of combinations (1:1 ratio) of selected tunicamycin and 
nicotine concentrations on early apoptosis in MCF-7 cells after 48 
hrs of exposure (20 000 events analysed) 
Concentration 
(µM) Dead Cells 
Dead 
Apoptotic 
Cells 
Live Cells 
Early 
Apoptotic 
Cells 
0 0.02 0.01 99.91 0.06 
0.01 0.95 3.74 94.63 0.69 
0.1 4.25 90.22 0.66 4.87 
1 2.15 90.27 0.44 7.13 
 
Table 29 indicates that at 0.1 µM and 1 µM, 90.22% and 90.27% of the respective 
populations were dead due to apoptosis while early apoptotic cells remained low for 
both concentrations, when compared to control. 0.01 µM had no effect on early 
apoptosis. 
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Table 30:    The effect of combinations (1:1 ratio) of selected tunicamycin and 
nicotine concentrations on early apoptosis in MCF-7 cells after 72 
hrs of exposure (20 000 events analysed) 
Concentration 
(µM) Dead Cells 
Dead 
Apoptotic 
Cells 
Live Cells 
Early 
Apoptotic 
Cells 
0 0.02 0.01 99.91 0.06 
0.01 0.93 4.9 90.54 3.62 
0.1 16.42 42.35 3.82 37.42 
1 14 43.55 3.98 38.47 
 
 
Table 30 shows that after 72 hrs at 0.1 and 1 µM of the combinations; 42.35% and 
43.55% cells entered early apoptotic phase, respectively. For both concentrations, the 
live cell populations was below 4% and early apoptotic populations were  at 37.42 
and 38.47%, respectively compared to control. 0.01 µM had a live cell population of 
90.54%. 
 
 
Fig. 66. The scatter plots created from flow cytometry analysis represent the controls 
used for comparison of the effects of the Tm:Nic (1:1) combination. a) 
Unstained MCF-7 cells, b) PI only stained MCF-7 cells and c) staurosporine 
treated, annexin V only stained MCF-7 cells (positive control). 
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Fig. 67. Scatter plots depicting the effect of 0.01 µM of tunicamycin and nicotine 
combinations on MCF-7 cells at a) 24 hrs, b) 48 hrs and c) 72 hrs. 
 
 
Fig. 68. The effects of 0.01 µM Tm:Nic on MCF-7 cells. 
 
Fig. 67 and 68 displays the effect of 0.01 µM of the (1:1) combination of Tm:Nic over 
time. At 24 hrs, early apoptotic cells were similar to 48 hrs and 72 hrs of exposure. 
Dead apoptotic cells were also similar when compared at 24, 48 and 72 hrs.   
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Fig. 69. Scatter plots depicting the effect of 0.1 µM of Tm:Nic combinations at a) 24 
hrs, b) 48 hrs and c) 72 hrs. 
 
 
 
Fig.70. The effects of 0.1 µM Tm:Nic on MCF-7 cells. 
 
Fig. 69 and 70, illustrates the change in population when MCF-7 cells were exposed 
to 0.1 µM of the Nic and Tm combination. Early apoptotic cell populations decreased 
from 14.22% at 24 hrs to 4.87% after 48 hrs. At 72 hrs, an increase of 37.42% in early 
apoptotic population was observed while cells dead due to apoptosis was at 42.35% 
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Fig. 71. Scatter plots depicting the effect of 1 µM of Tm:Nic at a) 24 
hrs, b) 48 hrs and c) 72 hrs. 
 
 
 
Fig. 72. The effects of 1 µM Tm:Nic on MCF-7 cells. 
 
At 1 µM of Tm:Nic, 20% of the population was in early apoptosis after 24 hrs, which 
declined after 48 hrs to 7.13% and inclined after 72 hrs to 38.47%. Dead apoptotic 
cells at 24 hrs were at 12.49%, 48 hrs were at 90.27% and at 72 hrs were 43.55%, as 
shown in Fig. 71 and 72. 
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3.5 The combinatorial effect of Thapsigargin and Nicotine on MCF-7 cells 
3.5.1 Effect on cell viability 
 
Table 31:  
 
The effect of selected combinations (1:1) of thapsigargin and 
nicotine concentrations on MCF-7 cell viability (Mean ± SEM) 
Concentration 
(µM) 24 Hour 48 Hour 72 Hour 
0.0001 110.369 ± 4.177 122.934 ± 5.218 105.015 ± 2.694 
0.001 113.056 ± 2.656 115.756 ± 3.322 108.897 ± 4.315 
0.01 89.099 ± 1.336 108.340 ± 1.885 105.051 ± 2.277 
0.1 65.683 ± 2.756 49.848 ± 1.916 53.762 ± 9.925 
1 62.954 ± 2.554 39.599 ± 1.270 29.013 ± 4.456 
5 22.962 ± 3.316 15.404 ± 0.817 18.187 ± 1.009 
50 -11.935 ± 0.720 -0.497 ± 0.478 4.474 ± 1.120 
 
Table 31 shows the effects of Tg:Nic on MCF-7 % viability. At 0.1 and 1 nM, cell 
viability exceeded 100% across all time intervals and at 48 and 72 hrs for 10 nM 
concentration. A significant decline in viability was observed at 24 hrs between 1 µM 
and 50 µM. For 48 and 72 hrs (p<0.0001) and (p<0.0001) the significant decline was 
observed from 0.01 µM onwards.  
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Fig. 73. Effects of various Tg:Nic (1:1) concentrations on MCF-7 cells viability.  
  
Fig. 73 shows the effects of the combination between thapsigargin and nicotine on the 
MCF-7 cells after 24, 48 and 72 hours. 48 and 72 hrs shared similar trends while cells 
exposed for 24 hrs displayed delayed inhibitory effects.  
 
3.5.2 Effect on ATP production  
 
Table 32:  
 
The effect of selected combinations (1:1) of thapsigargin and nicotine 
concentrations on ATP production of MCF-7 cells (Mean ± SEM) 
Concentration 
(µM) 24 Hour 48 Hour 72 Hour 
0.1 58.920 ± 2.154 16.705 ± 0.128 12.138 ± 0.546 
1 57.282 ± 1.135 7.810 ± 0.141 5.340 ± 0.162 
5 52.748 ± 1.576 8.125 ± 0.343 5.223 ± 0.106 
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Table 32 represents the ATP activity in MCF-7 cells when exposed to Tg:Nic  
combinations. No differences were observed at 24 hrs, between any concentrations 
tested, nor at 48 or 72 hrs of incubation. However, % ATP was significantly higher 
(p≤0.0286) when compared to 48 and 72 hrs.  
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Fig. 74. The effects of selected Tg:Nic (1:1) concentrations on ATP production. 
 
Fig. 74 illustrates the effects of the selected Tg:Nic concentrations on ATP production 
after 24, 48 and 72 hrs. At 24 hrs, ATP production was between a 50-60% range. 
However, after 48 and 72 hrs, ATP was noticeably reduced to below 20% and 
remained suppressed as the concentrations increased.  
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3.5.3  Effect on DNA proliferation  
Table 33:  
 
The effect of selected  combinations of thapsigargin and nicotine (1:1) 
concentrations on DNA proliferation of MCF-7 cells (Mean ± SEM) 
Concentration 
(µM) 24 Hour 48 Hour 72 Hour 
0.1 16.71± 1.422 190.005 ± 26.615 179.32 ± 8.098 
1 16.255 ± 2.372 176.26 ± 23.817 218.383 ± 16.686 
5 11.238 ± 1.134 171.203 ± 9.503 247.283 ± 9.111 
 
Table 33 shows the effect Tg:Nic (1:1) had on DNA proliferation at each time 
interval. DNA levels were significantly lower (p≤0.0286) at 24 hrs when compared to 
both 48 and 72 hrs, for all concentrations analysed. Furthermore, % DNA was 
noticeably higher at 1 and 5 µM ratios at 72 hrs when compared to 48 hrs. 
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Fig. 75. The effect of selected concentrations of Tg:Nic (1:1) combinations 
on DNA synthesis in MCF-7 cells at 24, 48 and 72 hrs. 
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Fig. 75 compares the effects of Tg:Nic on MCF-7 cells’ DNA proliferation after 24, 
48 and 72 hrs. At 24 hrs a low level of proliferation was observed across 
concentrations, however, after 48 hrs, proliferation amplified significantly in 
percentage and decreased with a trend as concentrations increased. At 72 hrs, 
proliferation of the DNA remained significantly augmented and increased as 
concentration increased. 
 
3.5.4 Effect on cells viability, ATP and DNA proliferation 
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Fig. 76. The combinatorial effects of 24 hr Tg:Nic (1:1) on cell viability, ATP and 
DNA proliferation. 
 
Fig. 76 represents the effects of thapsigargin and nicotine (1:1) combination of MCF-
7 cells after 24 hrs. % viability and ATP were similar at 0.1 and 1 µM, however while 
ATP levels remained similar at 5 µM, % viability decreased significantly. The % 
DNA proliferation remained lower for all concentrations.   
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Fig. 77. The effect of 48 hr exposure on MCF-7 cells to selected Tg:Nic (1:1) 
concentrations.  
 
After 48 hrs of exposure to the combination of thapsigargin and nicotine, Fig. 77 
shows that although viability and ATP production was below 50%, DNA proliferation 
increased to above 150%. 
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Fig. 78. The effect of Tg:Nic (1:1) induced MCF-7 cells after 72 hrs.  
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Fig. 78 graphically represents the effects of exposing MCF-7 cells to selected 
concentration of nicotine and thapsigargin (1:1) combination for 72 hrs. Viability and 
ATP production were suppressed while proliferation of DNA had exceeded 200%. 
 
3.6.5 Early apoptotic effects on MCF-7 cells  
Table 34: The effect of selected combinations of thapsigargin and nicotine 
(1:1 ratio) concentrations on early apoptosis in MCF-7 cells after 24 
hrs of exposure (20 000 events analysed) 
Concentration 
(µM) Dead Cells 
Dead 
Apoptotic 
Cells 
Live Cells 
Early 
Apoptotic 
Cells 
0 0.02 0.01 99.91 0.06 
0.1 0.92 7.38 81.02 10.68 
1 3.13 14.34 74.85 7.68 
5 1.79 6.67 85 6.53 
 
Table 34 shows that for all concentrations analysed live cell populations were above 
74% and early apoptotic cells were less affected (between 6 and 11%). Similar trends 
were observed for dead apoptotic cells.  
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Table 35:   The effect of selected combinations of thapsigargin and nicotine 
(1:1 ratio) concentrations on early apoptosis in MCF-7 cells after 48 
hrs of exposure (20 000 events analysed) 
Concentration 
(µM) Dead Cells 
Dead 
Apoptotic 
Cells 
Live Cells Early Apoptotic Cells 
0 0.02 0.01 99.91 0.06 
0.1 8.3 75.85 7.49 8.36 
1 0.42 88.23 3.42 7.93 
5 1.26 83.07 8.87 6.79 
 
Table 35 shows a reduction in live cell population across concentrations and an 
incline in dead apoptotic cell populations after 48 hrs. Early apoptotic cells remained 
under 10% for all concentrations investigated. 
 
Table 36: The effect of selected combinations of thapsigargin and nicotine (1:1 
ratio) concentrations on early apoptosis in MCF-7 cells after 72 hrs of 
exposure (20 000 events analysed) 
Concentration 
(µM) Dead Cells 
Dead 
Apoptotic 
Cells 
Live Cells 
Early 
Apoptotic 
Cells 
0 0.02 0.01 99.91 0.06 
0.1 2.07 4.42 91.04 2.48 
1 1.11 3.44 91.75 3.71 
5 10.63 39.33 5.51 44.53 
 
Table 36 shows an increase in both apoptotic populations as concentrations increased. 
At 5 µM, 5.51% of the cells were alive and 44.53% were undergoing early apoptosis. 
At 0.1 µM and 1 µM, similar effects were observed. 
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Fig. 79. The scatter plots created from flow cytometry analysis represent the controls 
used for comparison of the effects of the Tg:Nic combination. a) Unstained 
MCF-7 cells, b) PI only stained MCF-7 cells and c) staurosporine treated, 
annexin V only stained MCF-7 cells (positive control). 
 
Fig. 80. Displays the scatter plots, a) 24 hr exposure b) 48 hrs and c) 72 hrs of 
Tg:Nic (1:1) exposure.  
 
 
 
Fig. 81. The effects of 0.1 µM Tg:Nic on MCF-7 cells. 
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Fig. 80 and 81 illustrates that the combination of Tg:Nic. At 48 hrs, the dead cell 
population had increased to 75.85% and decreased to 4.48% at 72 hrs. 
 
Fig. 82. Scatter plots depicting the effect of 1 µM of thapsigargin and 
nicotine combinations at a) 24 hrs, b) 48 hrs and c) 72 hrs. 
 
 
Fig. 83. The effects of 1 µM Tg:Nic on MCF-7 cells. 
 
Fig. 82 and 83 show that, 88.23% were dead due to apoptosis after 48 hr exposure to 1 
µM combination, which decreased to 3.44% at 72 hrs. Early apoptotic cells were 
inversely proportional to time and concentrations. 
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Fig. 84. Scatter plots depicting the effect of 5 µM of thapsigargin and nicotine 
combinations at a) 24 hrs, b) 48 hrs and c) 72 hrs.  
 
 
Fig. 85. The effects of 5 µM Tg:Nic on MCF-7 cells. 
 
Fig. 84 and 85 show that between 24 and 72 hrs, early apoptotic cell population 
increased. Dead apoptotic cells between 48 and 72 hrs decreased from 83.07% to 
39.33%, while the early apoptotic population increased to 37.74% . 
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3.6 The combinatorial effect of Tunicamycin and Thapsigargin on MCF-7 
cells 
3.6.1 Effect of 0.105 µM Tunicamycin in combination with selected 
Thapsigargin concentrations 
3.6.1.1 Effect on cell viability 
 
Table 37: The effect of selected thapsigargin concentrations in combination 
with 0.105 µM tunicamycin on MCF-7 cell viability (Mean ± SEM) 
Time 
(Hours) 
0.105 Tm 
0.03 Tg 0.06 Tg 0.12 Tg 
24 43.705 ± 0.648 48.541 ± 1.701 49.415 ± 2.448 
48 29.155 ± 2.159 34.477 ± 0.910 11.122 ± 1.877 
72 38.368 ± 2.169 22.00 ± 0.550 8.279 ± 1.484 
 
Table 37 shows the effect of 0.105 µM Tm in combination with selected Tg 
concentrations. Viability was similar at 24 hrs for all concentrations analysed. The % 
viability did not exceed 49.415 ± 2.448%. At 48 hrs, the lowest and highest Tg 
combinatorial concentration of 0.03 and 0.12 µM displayed higher viability when 
compared to Tg 0.06 µM. The viability was significantly higher (p≤0.0022) at Tg 0.12 
combination at 24 hrs when compared to 48 and 72 hrs.  
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Fig. 86. The effect of selected Tg concentrations in combination with 0.105 µM Tm 
on the viability of MCF-7 cells. 
 
Fig. 86 shows the effects of various selected Tg concentrations against 0.105 µM of 
Tm, for the various time intervals. Viability remained similar at 24 hrs while a marked 
decrease was noted at the higher concentration combinations at 48 hrs. At 72 hrs, a 
steady decrease in viability occurred as concentrations increased. The intermediate Tg 
concentration combined with Tm, had the greatest inhibitory effects on viability.  
  
0.03 Tg                       0.06 Tg                        0.12 Tg 
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3.6.1.2 Effect on ATP production  
 
Table 38: The effect of selected thapsigargin concentrations in combination 
with 0.105 µM tunicamycin on ATP production in MCF-7 cells 
(Mean ± SEM) 
Time 
(Hours) 
0.105 Tm 
0.03 Tg 0.06 Tg 0.12 Tg 
24 62.962 ± 1.464 58.52 ± 1.531 55.076 ± 0.995 
48 13.288 ± 0.702 12.345 ± 0.566 11.413 ± 0.473 
72 9.251 ± 0.414 7.414 ± 0.115 6.594 ± 0.118 
 
Table 38 displays the effect of thapsigargin and tunicamycin combinations on MCF-7 
cells’ ATP production. For all concentrations ATP production remained the same for 
each time interval. Each concentration combination over time resulted in a significant 
decrease (p≤0.0286) between 24 and 48 hrs, while no differences were observed 
between 48 and 72 hrs.  
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Fig. 87. The effect of selected concentrations of Tg in combination with 
0.105 µM Tm on ATP Production in MCF -7 cells. 
 
Fig. 87 displays a statistical inhibition in % ATP after 48 and 72 hrs (p≤0.0286). At 
48 and 72 hrs, ATP levels remained the same at all concentrations analysed.  
 
3.6.1.3  Effect on DNA proliferation  
Table 39: The effect of selected thapsigargin concentrations in combination 
with 0.105 µM tunicamycin on DNA proliferation of MCF-7 cells 
(Mean ± SEM)  
Time 
(Hours) 
0.105 Tm 
0.03 Tg 0.06 Tg 0.12 Tg 
24 35.894 ± 2.676 33.287 ± 2.524 22.440 ± 6.239 
48 88.56 ± 8.362 102.457 ± 9.775 80.503 ± 8.681 
72 65.243 ± 8.365 45.935 ± 4.629 48.790 ± 7.170 
 
0.03 Tg                      0.06 Tg                     0.12 Tg 
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Table 39 displays the effect of the combined Tm and Tg concentrations on DNA 
proliferation in MCF-7 cells. DNA proliferation increased between the combination 
of Tm and Tg 0.03 and 0.12 µM at 24 and 48 hrs were similar. However, at Tg 0.06 
(p=0.0238) when comparing 24 to 48 hr proliferation. No differences were observed 
between 0.03 µM and 0.06 µM Tg combinations at 24 hrs, however the % DNA 
proliferation increased at 48 hrs. DNA proliferation was similar between 0.03, 0.06 
and 0.12 µM Tg combination at 72 hrs. Significant differences were only observed 
between 24 and 48 hrs at 0.06 µM Tg (p=0.0238) and between 24 and 72 hrs at 0.06 
µM Tg (p=0.0381).  
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Fig. 88. The effect of selected Tg concentrations in combination with 0.105 µM Tm 
on DNA proliferation in MCF-7 cells. 
 
DNA proliferation between 24 and 48 hrs saw an increase while between 48 and 72 
hrs, % DNA proliferation decreased. The highest % proliferation was observed at 48 
hrs. 
 
  
   0.03 Tg                     0.06 Tg                       0.12 Tg 
 
 
 
 
107 
 
3.6.1.4 Effect on cell viability, ATP and DNA proliferation 
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Fig. 89. The effect of 0.105 µM Tm in combination with various Tg 
concentrations after 24 hrs of exposure. 
 
Fig. 89 illustrates the effect of Tm and Tg combinations on viability, ATP activity and 
DNA proliferation, at 24 hrs. It was observed that, viability was approximately 50% 
for all concentrations, and ATP activity was slightly elevated with a significant 20% 
increase at the Tg 0.03 combination. % DNA proliferation however, decreased as 
concentrations increased. 
 0.03 Tg                     0.06 Tg                         0.12 Tg 
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Fig. 90. The effect of Tm 0.105 µM in combination with various Tg 
concentrations at 48 hrs exposure on % viability, % ATP and % 
DNA proliferation. 
 
After 48 hrs, both viability and ATP levels are below 40%. However, % DNA 
proliferation was significantly higher at approximately 80% for all combinations of 
concentrations. 
0.1
0
20
40
60
80
100
Viability
Proliferation
ATP
 Concentration (M)
%
 
Fig. 91. The graph represents the effect of Tm 0.105 µM in combination 
with various Tg concentrations at 72 hrs.  
  0.03 Tg                     0.06 Tg                   0.12 Tg 
 0.03 Tg                     0.06 Tg                         0.12 Tg 
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After 72 hrs viability decreased as the Tg concentrations increased (Fig. 91). ATP 
activity remained below 20% for all concentrations analysed. The only statistical 
significance observed was between combinations of 0.105 µM Tm and 0.03 µM Tg.  
DNA proliferation when compared to viability and ATP, was elevated after 72 hrs. 
3.6.1.5 Early apoptotic effects on MCF-7 cells 
 
Table 40: The effect of selected thapsigargin concentrations in combination 
with 0.105 µM tunicamycin on early apoptosis in MCF-7 cells after 
24 hrs (20 000 events analysed) 
Concentration 
(µM) 
Dead cells 
 
Dead 
Apoptotic 
Cells 
Live Cells 
Early 
Apoptotic 
cells 
0.105 
Tm 
0.03 Tg 0.35 9.74 80.56 9.35 
0.06 Tg 0.84 9.87 77.95 11.34 
0.12 Tg 1.56 14.77 70.73 12.91 
 
Table 40 displays that for all combinations, at 24 hrs, the majority of the populations 
remained unaffected.  The cell population in early apoptosis did not exceed 12.91% 
for all concentration combinations.   
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Table 41: The effect of various thapsigargin concentrations in combination 
with 0.105 µM tunicamycin on early apoptosis in MCF-7 cells after 
48 hrs (20 000 events analysed) 
Concentration 
(µM) 
Dead cells 
 
Dead 
Apoptotic 
Cells 
Live Cells 
Early 
Apoptotic 
cells 
0.105 
Tm 
0.03 Tg 8.02 85.76 0.51 5.71 
0.06 Tg 2.74 89.69 0.58 6.99 
0.12 Tg 3.11 90.19 1.59 5.11 
 
Table 41 shows that on average 89% of the population, at all combinatorial 
concentrations, were dead due to apoptosis and approximately 5.5% of the cells were 
undergoing early apoptosis.  
 
Table 42: The effect of various thapsigargin concentrations in combination 
with 0.105 µM tunicamycin on early apoptosis in MCF-7 cells after 
72 hrs (20 000 events analysed) 
Concentration 
(µM) 
Dead cells 
 
Dead 
Apoptotic 
Cells 
Live Cells 
Early 
Apoptotic 
cells 
0.105 
Tm 
0.03 Tg 16.82 44.49 2.83 35.86 
0.06 Tg 11.61 47.27 2.05 39.07 
0.12 Tg 10.38 57.85 0.76 31.01 
 
Table 42 demonstrates that after 72 hrs of exposure to the various combinations of Tm 
and Tg, an average of 49% of the population analysed, were dead due to apoptosis 
and approximately 33% of the population were undergoing early apoptosis.   
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Fig. 92. Flow cytometry controls. a) Unstained MCF-7 cells, b) PI only stained MCF-
7 cells and c) staurosporine treated, annexin V only stained MCF-7 cells 
(positive control). 
 
 
Fig. 93. Scatter plots depicting 0.105 Tm:0.03 µM Tg combination at a) 24 hrs, b) 48 
hrs and c) 72hrs. 
 
 
Fig. 94. The effects of 0.105 Tm:0.03 µM Tg on MCF-7 cells. 
 
Fig. 93 and 94 shows the effects of the 0.105 Tm:0.03 µM Tg combination over time. 
As time increased the amount of dead cells increased. At 48 hrs approximately 
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85.76% were dead apoptotic cells and, at 72 hrs the population decreased to 
approximately 45%, with 35.86% of cells in early apoptotic phase. 
 
 
Fig. 95. Scatter plots depicting the effects of 0.105 Tm:0.06 µM Tg combinations at 
a) 24 hrs, b) 48 hrs and c) 72hrs. 
 
 
Fig. 96. The effects of 0.105 Tm:0.06 µM Tg on MCF-7 cells. 
 
Early apoptotic cell populations increased as incubation times increased (Fig. 95 and 
96). Dead apoptotic cells increased after 48 hrs, but decreased after 72 hrs of exposure 
to the 0.105 µM Tm and 0.06 µM Tg combinations. Early apoptotic population 
increased by 28.73% between 24 and 72 hrs.  
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Fig. 97. Scatter plot depicting the effect of 0.105 Tm:0.12 µM Tg combination at a) 
24 hrs, b) 48 hrs and c) 72hrs. 
 
 
Fig. 98. The effects of 0.105 Tm:0.12 µM Tg on MCF-7 cells. 
 
MCF-7 cells exposed to 0.105 Tm:0.12 µM Tg over time (Fig. 97 and 98) showed an 
increase in dead apoptotic cells after 48 hrs. At 72 hrs the population of dead 
apoptotic cells decreased to 57.85%, while early apoptotic cells increased as 
incubation time doubled. After 48 hrs, live cell populations decreased below 1%.  
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3.6.2 Effect of 0.06 µM Thapsigargin in combination with selected 
Tunicamycin concentrations  
3.6.2.1 Effect on cell viability 
 
Table 43: The effect of selected tunicamycin concentrations in combination 
with 0.06 µM thapsigargin on MCF-7 cell viability (Mean ± SEM) 
Time 
(Hours) 
0.06 Tg 
0.0525 Tm 0.105 Tm 0.21 Tm 
24 48.745 ± 0.932 46.816 ± 2.311 50.986 ± 3.486 
48 22.108 ± 0.635 34.477 ± 0.910 19.412 ±2 .480 
72 19.018 ± 1.448 22.00  ± 0.550 31.862 ± 3.748 
 
 
Table 43 shows the effect of 0.06 µM Tg in combination with various tunicamycin 
concentrations on the cell viability of MCF-7 breast carcinoma cells. The 
combinatorial effect at 24 hrs was similar at all concentrations. At 48 hrs, viability 
was higher (p≤0.0022) at 0.105 µM combination when compared to 0.0525 and 0.12 
µM Tm. Viability at 72 hrs, showed that the highest Tm concentration combination 
resulted in the highest viability.  
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Fig. 99. The combinatorial effect of selected Tm concentrations with 0.06 µM Tg on 
MCF-7 cell viability. 
 
Fig. 99 illustrates the effect of the various Tm concentrations against 0.06 µM Tg. A 
significantly elevated (p≤0.0043) % viability was observed at 24 hrs when compared 
to 48 and 72 hrs. 
 
  
0.0525 Tm                    0.105 Tm                        0.21 Tm 
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3.6.2.2 Effect on ATP production  
 
Table 44: The effect of selected tunicamycin concentrations in combination 
with 0.06 µM thapsigargin on ATP production in MCF-7 cells (Mean 
± SEM) 
Time 
(Hours) 
0.06 Tg 
0.0525 Tm 0.105 Tm 0.21 Tm 
24  61.588 ± 0.898 58.52 ± 1.531 58.798 ± 1.369 
48  18.723 ± 1.044 12.345 ± 0.566 10.99 ± 0.637 
72  6.398 ± 0.151 7.414 ± 0.115 7.051 ± 0.359 
 
 
Table 44 illustrates the effects of the Tg:Tm combinations on ATP production in 
MCF-7 cells. ATP production was the same for all combinations at 24 hrs, but did not 
exceed 61.588 ± 0.898%. A significant decrease (p≤0.0286) was noticed between 24 
and 48 hrs, and 48 and 72 hrs for all combinatorial concentrations. No differences 
were observed between 0.105 µM Tm and 0.21 µM Tm, for both 48 and 72 hrs. 
However, a decrease was noted (p=0.0286) between 0.0525 and 0.105 µM Tm at 48 
hrs, while no difference in % ATP was observed at 72 hrs. 
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Fig. 100. The effect of various Tm concentrations in the presence 
of 0.06 µM Tg on % ATP activity in MCF-7 cells. 
 
Fig. 100 indicates that after 48 (p≤0.0286) and 72 hrs (p≤0.0286) of exposure a 
significant inhibition of ATP was observed in comparison with 24 hrs. Furthermore 
after 48 hrs ATP was below 20% and remained so even after 72 hrs. 
 
  
0.0525 Tm                 0.105 Tm                       0.21 Tm 
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3.6.2.3  Effect on DNA proliferation  
Table 45: The effect of selected tunicamycin concentrations in combinations 
with 0.06 µM thapsigargin on DNA proliferation in MCF-7 cell 
(Mean ± SEM) 
Time 
(Hours) 
0.06 Tg 
0.0525 Tm 0.105 Tm 0.21 Tm 
24 32.00 ± 3.831 33.287 ± 2.524 37.256 ± 1.261 
48 89.283 ± 13.019 102.457 ± 9.775 82.36 ± 10.714 
72 55.978 ± 3.899 45.935 ± 4.629 54.51 ± 5.4584 
 
No differences were observed between the various combinations for all time intervals. 
% DNA proliferation increased at 48 hrs, however it was only significant when 
compared to 24 hrs (p=0.0238) at 0.105 µM Tm. It decreased between 48 and 72 hrs 
and did not exceed 55.98%.  
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Fig. 101. The effect of 0.06 µM Tg in combination with selected Tm 
concentrations on DNA proliferation. 
 
After 48 hrs, a significant escalation in proliferation was detected. However after a 
further 24 hrs an approximate 40% decrease in proliferation was observed. 
 
  
0.0525 Tm                 0.105 Tm                     0.21 Tm 
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3.6.2.4 Effect on cell viability, ATP and DNA proliferation 
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Fig. 102. The effect of 0.06 µM Tg in combination with various Tm concentrations 
after 24 hrs exposure. 
 
Fig. 102, illustrates the effect of the combinations on viability, ATP activity and DNA 
proliferation. At 24 hrs it was observed that, ±50% viability was reached for all 
concentrations, ATP activity was at approximately 60% and proliferation did not 
exceed 37.3%. 
 
 
0.0525 Tm               0.105 Tm                       0.21 Tm 
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Fig. 103. The effect of 0.06 µM Tg in combination with various Tm concentrations at 
48 hrs exposure on % viability, % ATP and % DNA proliferation. 
 
After 48 hrs, both viability and ATP levels were below 40%. However, % DNA 
proliferation was significantly higher with at least a 50% increase across all 
combination concentrations. 
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Fig. 104. The graph represents the effect of 0.06 µM Tg in combination with various 
Tm concentrations at 72 hrs. 
0.0525 Tm                     0.105 Tm                          0.21 Tm 
0.0525 Tm                   0.105 Tm                       0.21 Tm 
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As concentrations increased (Fig.104) an increase in viability was observed but did 
not exceed 31.7%.  ATP activity remained below 10% for all concentrations analysed. 
DNA proliferation did not go below 45.94%. 
 
3.6.2.5 Early apoptotic effects on MCF-7 cells 
Table 46: The effect of selected tunicamycin concentrations in combination 
with 0.06 µM thapsigargin on early apoptosis in MCF-7 cells after 
24 hrs (20 000 events analysed) 
Concentration 
(µM) 
Dead cells 
 
Dead 
Apoptotic 
Cells 
Live Cells 
Early 
Apoptotic 
cells 
0.06 
Tg 
0.0525 Tm 1.23 40.17 51.98 6.62 
0.105 Tm 0.84 9.87 77.95 11.34 
0.21 Tm 0.75 7.57 79.17 12.51 
 
 
Table 46 displays the effect that Tg:Tm combinations had on the early apoptotic 
phase MCF-7 cells. The combination of 0.0525 µM Tm with 0.06 µM Tg resulted in 
51.98% live cells and a 40.17% dead apoptotic cell population, while the other 
selected combinations resulted in no more than 9.87% as a dead apoptotic population 
and a minimum of 77.95% were live cells. 
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Table 47: The effect of selected tunicamycin concentrations in combination 
with 0.06 µM thapsigargin on early apoptosis in MCF-7 cells after 
48 hrs (20 000 events analysed) 
Concentration 
(µM) 
Dead cells 
 
Dead 
Apoptotic 
Cells 
Live Cells 
Early 
Apoptotic 
cells 
0.06 
Tg 
0.0525 Tm 4.83 89.82 0.78 4.56 
0.105 Tm 2.74 89.69 0.58 6.99 
0.21 Tm 2.67 91.15 0.76 5.41 
 
Table 47 shows that dead apoptotic cell populations were between 89 and 92% for all 
combinations analysed at 48 hrs.  
 
Table 48: The effect of selected tunicamycin concentrations in combination 
with 0.06 µM thapsigargin on early apoptosis in MCF-7 cells after 
72 hrs (20 000 events analysed) 
Concentration 
(µM) 
Dead cells 
 
Dead 
Apoptotic 
Cells 
Live Cells 
Early 
Apoptotic 
cells 
0.06 
Tg 
0.0525 Tm 20.49 46.65 2.98 29.87 
0.105 Tm 11.61 47.27 2.05 39.07 
0.21 Tm 15.75 52.37 0.97 30.91 
 
Table 48 displays the effect after 72 hrs on MCF-7 cells induced with various 
combinations of Tm:Tg. Approximately 30% of cells treated with the combinatorial 
concentrations, had been inducted into early apoptosis for all concentrations. The 
dead apoptotic cell population was between 46 and 53% with the dead cell population, 
not exceeding 21%. 
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Fig. 105. Flow cytometry controls a) Unstained MCF-7 cells, b) PI only stained MCF-
7 cells c) staurosporine treated, annexin V only stained MCF-7 cells (positive 
control). 
 
 
 
 
Fig. 106. Scatter plots depicting the apoptotic effect of 0.0525 Tm:0.06 µM Tg 
combination on MCF-7 at a) 24 hrs, b) 48 hrs and c) 72 hrs. 
 
 
 
 
Fig. 107. The effects of 0.0525 Tm:0.06 µM Tg on MCF-7 cells. 
Fig. 106 and 107 show that after 24 hrs, dead apoptotic cell population was at 
40.17%, a further 24 hr incubation period, resulted in an increase in the apoptotic 
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population to 89.92%, which decreased after 72 hrs to 46.65%. Early apoptotic cell 
numbers increased by 23.28% between 24 and 72 hrs.   
 
 
Fig. 108. Scatter plots depicting the apoptotic effect of 0.105 Tm:0.06 µM Tg 
combination on MCF-7 at a) 24 hrs, b) 48 hrs and c) 72 hrs. 
 
 
 
Fig. 109. The effects of 0.105 Tm:0.06 µM Tg on MCF-7 cells. 
 
Scatter plots and pie graphs (Fig. 108 and 109) illustrate that early apoptotic cell 
populations increased by 27.73% between 24 and 72 hrs. Dead apoptotic cells 
numbers increased to 89.7% after 48 hrs, but decreased to 47.3% after 72 hrs with 
exposure to the Tm and Tg combinations.  
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Fig. 110. Scatter plots depicting the apoptotic effect of 0.21 Tm:0.06 µM Tg   
combination on MCF-7. 
 
 
 
Fig. 111. The effects of 0.21 Tm:0.06 µM Tg on MCF-7 cells. 
 
48 hrs of exposure to 0.21 µM Tm with 0.06 µM Tg resulted in an increase from 7.6% 
to 91.15% in dead apoptotic cell numbers, followed by a decreased of 52.4% after 72 
hrs. Early apoptotic population reached 30.91% while dead cell population reached 
15.8%. 
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CHAPTER 4 
 
4.  DISCUSSION AND CONCLUSION 
 
Normal cells undergo growth phases in order to maintain survival, which involves 
alterations within the cell in order to proliferate, repair or segregate the genome 
(Hartwell and Kastan, 1994). Cancerous cells, however, are mutated cells that have 
been genetically or phenotypically altered (Dervan, 2001). Tumourigenesis is the 
uncontrolled growth of mutated cells due to down regulation of tumour suppressor 
genes (TSGs) (Xiang et al., 2012). Although progress has been made in the 
diagnosing and managing of breast cancer, there are still limitations with regards to 
early detection of this disease and therefore there is a need to further elucidate breast 
cancer mechanisms and identify potential anti-cancer promoting agents. 
 
Nicotine is an alkaloid known to deregulate critical signalling pathways in different 
systems functions and acts as a tumour promoter and displays anti-apoptotic 
characteristics (Zeidler et al., 2007). In this study it was observed that viability was 
unaffected by nicotine exposure. Furthermore, an increase was observed between 48 
and 72 hrs, with higher concentrations of nicotine resulting in a greater increase in 
viability. These findings indicate that exposure to this alkaloid supported cell 
proliferation. This was also observed and reported by Dasgupta et al., 2009. Catassi et 
al., 2008, Hirata et al., 2010, and Shin and Cho, 2005. They further reported that 
nicotine sheltered various cell lines from apoptosis when combined with compounds 
such as tunicamycin and doxorubicin (Zhou et al., 2007).  
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The increase in cell viability correlating to the increase of nicotine concentrations was 
also reported by Zhou and co-workers (2007). Similarly to viability, ATP and DNA 
proliferation in MCF-7 cells exposed to nicotine increased with the incubation 
periods. Nicotine was unable to induce early apoptosis at any concentration and any 
time interval analysed. These findings thus support previous work reporting on the 
tumour promoting properties of nicotine. 
 
It has been reported that combinations of nicotine and compounds known for their 
potential anti-cancer properties (exhibiting extreme toxicity towards cells), may 
provide a therapeutic tool against tumour progression (Zhou et al., 2007). Our study 
investigated the combinatorial effects if nicotine and tunicamycin (Tm) as well as 
nicotine and thapsigargin (Tg) on MCF-7 cells in an attempt to induce apoptosis and 
simultaneously significantly reduce the Tm or Tg-treated toxicity. In order to 
determine the appropriate concentrations to be used in combination with nicotine, the 
effect of the single pure compounds, viz; Tm and Tg on cell viability had to be 
analysed. Thus if cell death was observed in this study, using the selected 
concentrations at which significant viability was still evident, it could be proposed 
that the cellular arrest was through apoptotic mechanisms and not as a result of 
toxicity.  
 
It is known that Tm induces ER stress by interfering with the glycoslylation of newly 
synthesised proteins. The UPR is a homeostatic response to the accumulation of 
misfolded or anomalous proteins (Hiss et al., 2007). ER stress occurs when the UPR 
is unable to respond adequately resulting in an accumulation of perturbant proteins 
within the cell.  In this study it was demonstrated that, Tm decreased cell viability at 
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24, 48 and 72 hrs. The MCF-7 cells were unable to increase viability after 48 and 72 
hrs at higher Tm concentrations. However, at low concentrations, MCF-7 cells 
recovered from the inhibitory effects of Tm. From this study it was apparent that the 
effects of Tm on MCF-7 cells are dose-dependent as well as time dependent. These 
findings were also reported by Semmes and co-worker (1992), He et al. (2009) and 
Hiss et al. (2007). 
 
Tm concentrations selected for the analyses of ATP production, resulted in a 
maximum of 50% cell viability. The rationale for selecting these concentrations stems 
from the reported ability of nicotine to suppress apoptotic properties of Tm (Zhou et 
al., 2007) and thus an increase in cell viability was expected when combining nicotine 
and Tm (discussed later in the chapter). The ATP levels in cells treated with the 
selected Tm concentrations were highest at 24 hrs when compared to 48 or 72 hrs. 
However, the various concentrations of Tm analysed, had no effect on the ATP levels 
produced by the MCF-7 cells, at any specific time interval. The decreased ATP 
concentrations observed as a result of Tm exposure may have resulted in the 
decreased viability reported in this study. Recently Wang et al. (2011) reported that 
Tm inhibited cell proliferation in Bak-/-Bax-/- IL-3-dependent cells. They further 
reported that Tm inhibited glucose uptake and significantly reduced lactate production 
suggesting that Tm inhibited the glycolytic pathway. Studies have demonstrated that 
inhibition of the glycolytic pathway results in significantly depleted ATP in cancer 
cells (Xu et al., 2005). Thus interfering with the glycolytic pathway will affect the 
cell’s survival rate. The abovementioned findings support the data obtained in this 
study, demonstrating that Tm exposure to MCF-7 cells decreased viability and ATP 
production possibly as a result of the inhibition of glycolysis. 
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DNA proliferation analysis was determined using the same selected concentrations as 
ATP analyses. It was observed that the MCF-7 cells’ DNA concentrations were 
significantly low at 24 hrs. The DNA levels then noticeably increased by 48 hrs and 
were at substantially elevated levels at 72 hrs. However, the proliferation was not 
affected by the various concentrations of Tm at a specific time interval. While it was 
observed that Tm resulted in a decrease in cell viability and ATP production, it in 
contrast increased DNA proliferation. Studies have demonstrated that Tm resulted in a 
decrease in DNA levels and more specifically that the cells arrested in the G1 phase. 
However, these findings were based on exposure to Tm for less than 48 hrs (Hsu et 
al., 2009), while this study continued to 72 hr incubations. Moreover, studies reported 
that the ability to resist or reverse Tm effects were cell type dependent, in which they 
demonstrated that even after solid tumour variants of Chang hepatoma cells were 
blocked in the G1 phase by low Tm concentrations, they could still divide in the 
presence of Tm up to 8 days (Savage and Baur, 1983). The increased DNA 
proliferation observed at 72 hrs may be explainable based on the studies by Savage 
and Baur (1983) in which it is possible that some MCF-7 cells were blocked in the G1 
phase and others were blocked in the S phase. 
 
The effect of Tm on early apoptosis in MCF-7 cells, were determined by inducing 
cells with the same concentrations used for ATP and DNA analysis. The results 
obtained indicated that, Tm had slightly increased early apoptosis in MCF-7 cells at 
24 hrs. At 48 and 72 hrs, Tm resulted in their significant induction of apoptosis. The 
higher cell viability and ATP observed at 24 hrs correlated with the low apoptotic 
effects induced at 24 hrs. Furthermore, the decreased viability and ATP 
concentrations noted at 48 and 72 hrs was accompanied by the significant increase in 
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early apoptosis. This study conclusively demonstrated that Tm induced early 
apoptosis in MCF-7 cells at concentrations that were not toxic to the in vitro cell line. 
Furthermore, it was established that the decreased viability was associated with a 
decrease in ATP production. 
 
Thapsigargin (Tg), is known to induce ER stress by inhibiting its Ca2+-ATPase and 
thus blocking ER’s sequestration of Ca2+ leading to an increase in cytosolic levels. 
When intracellular Ca2+ levels increase, it elicits GRP78 expression linked to the 
UPR, indicating an ER stress response (Takadera et al., 2007). In this study, it was 
observed that viability was dose dependent, and decreased as concentrations 
increased, at all, time intervals. It was also noted that at lower concentrations of Tg, 
cell viability remained unaffected and comparable between 24 and 72 hrs. The 
inhibitory effects of Tg on MCF-7 viability was also reported by Thastrup et al. 
(1990) and Takadera et al. (2007). It must be highlighted that while this study 
validates previous findings, it is the first report on long term exposure to Tg. 
 
ATP analysis of selected Tg concentrations resulting in cell viability of approximately 
50%, showed that the various concentrations of Tg analysed at a specific time 
interval, had no effect on the ATP levels produced by the MCF-7 cells,. However, an 
increase in incubation periods resulted in a decrease in ATP levels for all Tg 
concentrations, except at the lowest concentration of 0.05 µM.  The decrease in ATP 
production observed over time may be correlated with the decrease in viability 
demonstrated. Tg’s mechanism of action is based on its ability to block the ER Ca2+-
ATPase and thus induce cellular arrest. This study demonstrated a significant decrease 
in ATP production and the mechanism for the decrease has been linked to enlarged 
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mitochondria associated with disrupted cristae structure. It was reported that as an 
adaptive response to ER stress, an early increase in the induction of mitochondrial 
metabolism occurs which may explain the significant decrease in ATP levels 
observed (Beaver and Waring, 1996, Bravo et al., 2011). Studies have reported that 
the absence of ATP supports the inhibitory effects of Tg (Thastrup et al., 1990) and 
thus the findings in this study further support the decrease in ATP observed.  
 
DNA proliferation analyses in the presence of Tg saw a significant increase as 
incubation time increased. The DNA levels at 24 hrs were noticeably lower when 
compared to 48 hrs. At 72 hrs, DNA proliferation had increased by more than 2- fold 
when compared to 48 hrs.  However, the proliferation was similar when comparing 
the effects of the various concentrations at the specific time intervals. The low DNA 
concentrations observed at 24 hrs could be correlated to the suppressed ATP and 
viability levels. Interestingly as was observed for Tm, the DNA concentrations 
between 48 and 72 hrs were significantly elevated in comparison to the markedly 
decreased ATP and viability. Previous findings report that Tg may result in cellular 
arrest at the G0 (Beaver and Waring, 1996), the G1 or G2 phase (Bourougaa et al., 
2010). Bourougaa and co-workers (2010) demonstrated that the phase of cellular 
arrest is dependent on the cell type and their p53 isoform expressed and is thus 
pathway-specific. The results obtained in this study therefore suggest that the MCF-7 
cells are blocked in the G2 phase. Similar to the proposed mechanism of Tm, it is 
possible that some MCF-7 cells were blocked in the G0/1 phase while others may 
have been blocked in the G2 phase with exposure to Tg and may explain the increase 
in DNA proliferation. This hypothesis needs further investigating. 
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MCF-7 cells exposed to Tg showed a high live cell percentage at 24 hrs (except at 
0.4µM) and did not induce early apoptosis. The live cell population decreased at 48 
and 72 hrs when compared to 24 hrs. At 48 hrs, a significant increase in dead 
apoptotic cell populations was observed, indicating that Tg had the ability to induce 
apoptosis in MCF-7 cells. At 72 hrs, early apoptotic cell populations increased and a 
decrease in dead apoptotic cells were observed. Thus validating that Tg did not 
decrease viability due to toxicity, but activated apoptotic mechanism, even at 
incubation periods of 72 hrs.  
 
Utsumi and co-workers (2004) demonstrated that nicotine had protective effects in 
Tm-treated PC12 cells in a dose-dependent manner. Sasaya et al. (2008) further 
validated these findings by reporting that GRP78’s expression was suppressed when 
Tm was combined with nicotine in PC12 cells. In this study it was observed that 
combinations of nicotine and Tm (ratio 1:1) concentrations significantly decreased 
viability of MCF-7 cells, at all selected time intervals. It was observed that 1 µM Tm 
resulted in 46.18±0.918 % viability at 24 hrs. In order to produce the same effect on 
viability, 100 µM Tm in combination with 100 µM Nic was required, demonstrating 
the apoptotic-suppressing effects of Nic. Nic also supported MCF-7 cells against Tm 
at 48 and 72 hrs, resulting in more than 100% increase in viability for the 
abovementioned concentration ratios. The anti-apoptotic properties of nicotine in 
combination with Tm, was also reported by Utsumi et al. (2004) and Sasaya et al. 
(2008) in PC12 cells. 
 
The combination of Tm and Nic showed a significant decrease in ATP production at 
24 hrs. Comparative analysis of the effect of 1 µM Tm at 24 and 72 hrs to the 
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combinatorial effects of 1 µM Tm: 1 µM Nic showed that the ATP concentrations 
were similar. However, at 48 hrs, ATP levels were significantly lower for the Tm:Nic 
combinations when compared to effects of the single compound. The decreased ATP 
concentrations observed correlated with the decreased cell viability as a result of 
Tm:Nic combinations. It is important to note that while the addition of Nic resulted in 
an increased viability, it did not affect the ATP concentrations when compared to the 
effects of the single compound, except when comparing 1 µM Tm to 1 µM Tm: 1 µM 
Nic at 48 hrs. To date, there is no literature reporting on the possible mechanism 
involving the combinatorial effects of Tm and Nic on ATP production in MCF-7 
cells. 
 
The same combination concentrations used for ATP analysis were employed in the 
determination of DNA proliferation. The results demonstrated that DNA levels 
decreased at 24 hrs while an increase in DNA concentrations were observed at both 
48 and 72 hrs. It was also noted while a decreased DNA proliferation was observed at 
the lowest combinatorial concentrations at 48 and 72 hrs compared to subsequent 
concentrations, overall the combinations resulted in a significant increase in DNA 
proliferation between 24 and 72 hrs. Furthermore the effects of the single compound 
at 1 µM displayed similar DNA proliferation when compared to the 1 µM Tm: 1 µM 
Nic combinations. 
 
It can be concluded that Tm:Nic (ratio 1:1) displayed a dose response where a 
decreased viability, ATP as well as DNA proliferation was observed at 24 hrs. At 48 
hrs, cells exposed to the 1:1 Tm:Nic ratio showed that viability and ATP was 
inhibited while DNA proliferation was increased. Similar effects were observed for 72 
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hrs, however, the DNA concentrations had increased by 2-fold when compared to 48 
hrs. This is the first report on the combinatorial effects of nicotine and Tm on ATP 
and DNA proliferation in MCF-7 cells between 24 and 72hrs. 
 
Analysis of apoptosis demonstrated that Tm:Nic (ratio 1:1) at 24 hrs resulted in higher 
live cell populations at the lowest concentration, while a decreased live cell 
population associated with an increased early apoptotic population was observed at 
the higher combinatorial concentrations. At 48 hrs an elevated live population was 
still observed at the lowest concentrations however, the higher concentrations induced 
a significant percentage of dead apoptotic cells. After 72 hrs, the dead apoptotic cell 
numbers decreased however remained significant and the early apoptotic cell numbers 
also increased. These results demonstrated that Tm:Nic (1:1 ratio) significantly 
induced early apoptosis, resulting in cell death in the MCF-7 cells between 24 and 72 
hrs. Discrepancies found between dead apoptotic and early apoptotic cells between 48 
and 72 hours, where dead apoptotic cells decreased significantly and early apoptotic 
cells increased, remains to be explained and thus requires reinvestigation. Moreover, 
the cell death was due to apoptosis and not as a result of toxicity. This finding had 
also been previously reported by Sasaya et al. (2008).  
 
Both the single compound and Tm:Nic combination at 1 µM resulted in comparable 
live and early apoptotic populations at 24 hrs. At 48 hrs, the dead apoptotic population 
was approximately 28% higher when exposed to the combinations when compared to 
the single compounds. Interestingly, at 72 hrs results showed both the single 
compound and combinations of Tm:Nic had similar effects on the early apoptotic 
populations. Therefore, from this study it can be concluded that nicotine supports cell 
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proliferation between 24 and 48 hrs, as previously reported (Utsumi et al., 2004, 
Sasaya et al., 2008). However, after 48 hrs nicotine no longer exhibits anti-apoptotic 
effects against Tm in MCF-7 cells. 
It is reported that nicotine did not suppress the apoptotic properties of Tg in PC12 
cells after 24 hrs. This study demonstrated that while Tg induced caspase 12 
expression (an apoptotic enzyme associated ER stress), its combination with nicotine 
did not result in a decrease in caspase 12 expression (Sasaya et al., 2008). To date, no 
other studies have reported on the combinatorial effects of Tg and nicotine. 1:1 ratio 
combinations of Nic and Tg showed a dose-response where viability had significantly 
decreased at, all time intervals analysed, except between the lowest concentrations. 
Significant decline in viability between 24 and 72 hrs was only observed between 
intermediate and highest concentrations. Although previous studies reported that 
nicotine did not suppress the apoptotic effects of Tg, this study showed that Tg:Nic 
(1:1 ratio) at 1 µM had higher cell viabilities at, all time intervals when compared to 
the effects of the single compound of 1 µM Tg. It was also noted while 1 µM Tg 
resulted in only 3.145 ± 0.386 % viability at 72 hrs, the Tg:Nic (1:1 ratio) at 1 µM 
resulted in 29.013 ± 4.456% viability. Moreover, using 5 µM 1:1 ratios of Tg:Nic, 
viability was still at 18.187 ± 1.009 %.  It must be concluded from this study that 
nicotine reduced the inhibitory effects of Tg on MCF-7 cell viability. Although in 
conflict with reports by Sasaya et al. (2008), it must be noted that this study was 
performed in human breast cancer cells over a period of 72 hrs, while the previous 
study reported on the effects for 24 hrs in PC12, prostate cancer cells. 
 
A significant decline in ATP concentration was observed for all combinatorial (1:1 
ratio) concentrations between 24 and 72 hrs. ATP levels however, remained the same 
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for all concentrations tested at specific time intervals. Interestingly, a comparison of 
the effect of 1 µM Tg compared to the combinatorial effects of the 1:1 ratio of 1 µM 
Tg:Nic, showed that the ATP levels were similar at 24 hrs, however, was significantly 
higher at 48 hrs, and then displayed similar significantly declined levels at 72 hrs. 
Overall, the single compound displayed similar trends to the combination of Tg:Nic.  
 
Viability significantly decreased when cells were exposed to various Tg:Nic 
combinations for 24 hrs, however, the ATP levels remained the same. When the 
single compound of Tg at various concentrations were was exposed to the MCF-7 
cells it resulted in similar viability accompanied by similar ATP levels. It is clear 
from previous studies that a decrease in ATP supported the inhibitory effects of Tg 
(Bravo et al., 2011). This study demonstrated that when Tg was in combination with 
nicotine, it had a greater inhibitory effect on ATP levels, particularly at 48 hrs, when 
compared to the effects of the single compound. It thus suggests that nicotine not only 
suppresses Tg toxicity but also aids in apoptotic signalling by causing significant ATP 
reduction. 
 
The same combination concentrations of Tg:Nic (ratio 1:1) used for ATP analysis 
were employed in the determination of DNA proliferation. The results showed that 
DNA levels significantly decreased at 24 hrs, while a dramatic increase in DNA 
concentration were observed at both 48 and 72 hrs. Thus the 1:1 ratios of Tg:Nic 
resulted in a significant increase in DNA proliferation between 24 and 72 hrs. 
Exposure to various concentrations of the single compound of Tg at 48 hrs resulted in 
significantly lower DNA levels than compared to the levels when exposed to 
combinations of Tg:Nic.  Overall, a decrease in viability was associated with a 
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decrease in ATP between 24 and 72 hrs, however, although a significantly low DNA 
concentration was observed at 24 hrs, the levels markedly increased after 72 hrs. 
 
Tg:Nic (ratio 1:1) did not induce early apoptosis at 24 hrs . However, at 48 hrs, it 
resulted in a markedly elevated dead apoptotic cell population. Interestingly, at 72 hrs, 
lower combinatorial concentrations resulted in a significant increase in live cell 
population, while the highest concentration of 5 µM resulted in 44.53% early 
apoptotic cells and 39.33% dead apoptotic cells. The effect of the single compound of 
0.4 µM Tg at 24 hrs, resulted in a 38.79% early apoptotic cell population whereas, the 
combinatorial 1:1 ratio of Tg:Nic for 1 µM resulted in only a 7.68% early apoptotic 
population. It is evident from this study, that nicotine decreased the pro-apoptotic 
effect of Tg in MCF-7 cells at 24 hrs as well as at 72hrs. At 48 hrs however, there 
were significantly more dead apoptotic cells as a result of the combinatorial 1:1 ratio 
of Tg:Nic for 0.1 µM, when compared to the single compound effect. 
 
Our findings suggest that nicotine displayed anti-apoptotic properties against Tm and 
Tg at 24 hrs in MCF-7 cells. However, between 48 and 72 hrs the suppressing effects 
of nicotine are no longer evident. Nicotine’s mechanism of action could possibly be 
through its ability to decrease expression of GRP 78, while Tm and Tg are known to 
increase its expression (Sasaya et al., 2008). This mechanism could explain the results 
obtained at 24 hrs, however, cannot explain the significant increase in apoptosis 
observed after 48 hrs in MCF-7 cells exposed to both Tm:Nic and Tg:Nic (1:1 ratio) 
combinations. 
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To date, no studies have investigated the combinatorial effects of Tm and Tg on 
MCF-7 cells. In an attempt to determine whether these compounds may have 
synergistic properties with respect to their apoptotic potential, various combinations 
were analysed. Initially, the IC50 concentrations were used in 1:1 ratios, but it resulted 
in 100% toxicity (data not shown). In order to demonstrate MCF-7 viability, 
concentrations less than 50% of the Tm and Tg IC50 concentrations were used for 
analysis. Results showed that when combining Tm at 50% (0.105 µM) of its IC50 with 
25% of the IC50 of Tg (0.03 µM), viability was below 50% and did not change 
between 24 and 72 hrs. Combinations of Tm (0.105 µM) with 0.06 µM Tg resulted in 
viability that was also below 50%, and decreased significantly between 24 and 72 hrs. 
When combining the Tm (0.105 µM) with 0.12 µM Tg, it again resulted in less than 
50% viability with a greater inhibitory effect between 24 and 72 hrs. Thus the higher 
the Tg concentration combined with Tm, the greater the decrease in % viability. 
Investigating the effect on ATP concentrations showed that all combinations had 
similar effects at the specific time interval analysed. The significant decrease in ATP 
levels observed between 24 and 72 hrs were similar for all combinations investigated. 
Even though higher Tg concentrations affected viability, it did not affect ATP 
production. 
 
Using the same combinations for DNA proliferation analysis, it was observed that 
there were no differences when comparing the combinatorial concentrations at any 
specific time interval. The DNA concentration for all combinations significantly 
increased between 24 and 48 hrs followed by a significant decrease after 72 hrs.  
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Effects of the combinations on apoptosis showed that all concentration combinations 
only induced a maximum of 12.9% cells in early apoptosis with a significant 
population of live cells. At 48 hrs, more than 85.76% of the cells were dead due to 
apoptosis. While at 72 hrs, more than 31.01% were in early apoptosis and less than 
57.8% were dead as a result of apoptosis. These findings demonstrated that the 
selected combinations of Tm and Tg induced apoptosis between 24 and 72 hrs. This 
study also showed that Tm in combinations with selected concentrations of Tg (below 
IC50) resulted in decreased viability, ATP concentrations and a noticeably lowered 
DNA proliferation. Furthermore, increasing the Tg concentration in combination with 
Tm resulted in greater inhibitory effects. 
 
Investigation into the combinatorial effects of Tg at 50% (0.06 µM) of its IC50 with 
25% of the IC50 of Tm (0.0525 µM) showed that viability was below 50% and did not 
change between 24 and 72 hrs. The combination of Tg (0.06 µM) with 0.105 µM Tm 
also resulted in viability below 50%, with a significant decrease between 24 and 72 
hrs. However, when combining the Tg (0.06 µM) with 0.21 µM Tm, it resulted in 
approximately 50% viability with a lesser inhibitory effect between 24 and 72 hrs. 
Thus the highest Tm concentration combined with 0.06 µM Tg, resulted in the least 
significantly inhibitory effect on viability between 24 and 72 hrs.  
 
Investigating the effect on ATP concentrations showed that all combinations had 
similar effects at the specific time interval analysed. The significant decrease in ATP 
levels observed between 24 and 72 hrs were similar for all combinations investigated. 
Thus the decreased viability was accompanied by decreased ATP concentrations.  
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The DNA proliferation was analysed with the same combinatorial concentrations as 
for ATP analysis. Results demonstrated that no differences occurred at any specific 
incubation period. The DNA concentration for all combinations significantly 
increased between 24 and 48 hrs followed by a substantial decrease by 72 hrs. This 
study showed that Tg in combinations with selected concentrations of Tm (below 
IC50) resulted in decreased viability, ATP concentrations and a significant lowered 
DNA proliferation.  
 
The apoptotic effects of the combinations showed that 0.06 µM Tg in combination 
with 0.0525 µM Tm resulted in 40.17% dead apoptotic cell population at 24 hrs. 
Whereas, subsequent concentrations, resulted in an elevated live cell population and a 
maximum of 9.87% dead apoptotic cells at 24 hrs.  At 48 hrs however, more than 
89.69% of the cells were dead due to apoptosis at all concentrations analysed. 72 hrs, 
displayed more than 29.87% in early apoptosis while less than 52.37% were dead as a 
result of apoptosis for all concentrations analysed. These findings verified that the 
selected combinations of Tg and Tm induced apoptosis between 24 and 72 hrs.  
 
Data demonstrated that both variations of Tm and Tg concentrations (in which a fixed 
concentration of Tm or Tg was used) could induce apoptosis. However, combinations 
of 0.105 µM Tm with 0.12 µM Tg resulted in more inhibition on cell viability than 
when combining 0.06 µM Tg with 0.21 µM Tm.  It must be noted that the effects of 
the combinations of Tm and Tg on ATP, DNA proliferation and apoptosis were 
similar. 
 
 
 
 
 
142 
 
Of interest to note, is that cells exposed to selected concentrations of the single 
compounds of Tm and Tg as well as the combinations of nicotine with Tm or Tg, 
resulted in a significant increase in DNA proliferation and induction of apoptosis. 
However, cells exposed only to combinations of Tm and Tg displayed significantly 
lowered DNA levels and still induced apoptosis. These findings suggest that the latter 
combinations activate different apoptotic pathways compared to the cellular 
mechanisms activated when cells are exposed to the single compounds and their 
combinations with nicotine. 
 
To date, there are no reports on the combinatorial effects of Tm and Tg on MCF-7 
cells. This study demonstrated that combinations of Tm and Tg were synergistic in 
their apoptotic potential and that when Tm concentrations were increased in 
combination with Tg, their synergistic relationship decreased. Further studies needs to 
be performed in order to establish the precise concentrations that would possibly 
result in an antagonistic relationship. 
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